gujarat technological university student list for m.pharm ...... · hydrochloride in fixed dose...

Sr. No. Date MAP_NUMBER Student_name sub codeBranch_C

ode

College_

Code

Branch_T

ypeBranch_name Micro Other_Micro DP1_TITLE Guide Name

Guide

Code

1 19-Nov-19 182060820002PANCHAL KUNAL PRAKASHCHANDRA (NON

PGCET)MRW304P 20 206 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF SUSTAINED RELEASE

BUCCAL TABLETS OF ZOLPIDEM TARTRATEDR.MITTAL MAHESHWARI 206

2 19-Nov-19 182060820004 Vekariya pareshkumar jagdishbhai MRW304P 20 206 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF GASTRORETENTIVE

MUCOADHESIVE TABLETS OF KETOROLAC

TROMETHAMINE

DR. MITTAL MAHESHWARI 206

3 19-Nov-19 182060824002 Patel Nidhi Shaileshbhai MRW304P 24 206 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF

STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION

OF DAPAGLIFLOZIN, SAXAGLIPTIN AND METFORMIN

HYDROCHLORIDE IN SYNTHETIC MIXTURE.

DR.NEHA TIWARI 206

4 19-Nov-19 182060824007 SHAH PRIYA MANISHKUMAR MRW304P 24 206 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT

AND VALIDATION FOR FERRIC MALTOL AND IT’S

PHARMACEUTICAL DOSAGE FORM

DR. PRAGNESH PATANI 206

5 19-Nov-19 182060824005 PRAJAPATI RAHUL CHINTAMANI (PGCET) MRW304P 24 206 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING HPLC METHOD DEVELOPEMENT

AND VALIDATION FOR THE ESTIMATION OF PEXIDARTINIB

IN PHARMACEUTICAL DOSAGE FORM

DR. NEHA TIWARI 206

6 19-Nov-19 182060824008 SIYOLA DHRUVI CHIMANBHAI (PGCET) MRW304P 24 206 MP

Pharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY)QUANTITATIVE

ESTIMATION

QUANTITATIVE ESTIMATION OF API IN SOME COMMONLY

USED BRANDED AND GENERIC ANTI HYPERLIPIDEMIC

DRUG USING VARIOUS SPECTROSCOPIC TECHNIQUES.

DR.PRAGNESH PATANI 206

7 19-Nov-19 182060824001 CHAUHAN JAYNISH NAVNITBHAI MRW304P 24 206 MP

Pharmaceutical

Quality

Assurance


ESTIMATION


USED BRANDED AND GENERIC ANTIDIABETIC DRUGS

USING VARIOUS SPECTROSCOPIC TECHNIQUES


8 19-Nov-19 182060824004PRAJAPATI ABHISHEK NARESHBHAI (NON

PGCET)MRW304P 24 206 MP

Pharmaceutical

Quality

Assurance


ESTIMATION


USED BRANDED AND GENERIC ANTIHYPERTENSIVE DRUGS

USING VARIOUS SPECTROSCOPIC TECHNIQUES


9 19-Nov-19 182080820003 PANDYA ARTH JAYESH MRW304P 20 208 MP Pharmaceutics

IR, ODT, DT, SUBLINGUAL,

FAST

DISPERSIBLE/DISSOLVI

FORMULATION AND EVALUATION OF ACETAMINOPHEN

MOUTH DISSOLVING TABLET.DR. DASHARATH M. PATEL 208

10 19-Nov-19 182080820004 PANDYA SHIVANI SHAILESHBHAI MRW304P 20 208 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF COMPRESSION-

COATED PULSATILE RELEASE TABLET OF ETODOLAC FOR

RHEUMATOID ARTHRITIS.

DR. UPENDRA L. PATEL 208

11 19-Nov-19 182080820005 PATEL AKASH BHAVDEEPBHAI MRW304P 20 208 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE

OF SILDENAFIL AND SUSTAINED RELEASE OF FLUOXETINE.MR. BHAVIN BHIMANI 208

12 19-Nov-19 182080820008 PATEL HIRANGI KIRTIKUMAR MRW304P 20 208 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF MICROSPHERES

BASED TOPICAL GEL OF APREMILAST.DR. HIRAL SHAH 208

13 19-Nov-19 182080820001 BHATT KAUSHIKKUMAR JAYANTKUMAR MRW304P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) LOZENGESFORMULATION AND EVALUATION OF MEDICATED

LOZENGES OF TRIAMCINOLONE ACETONIDE.MR. GHANSHYAM PATEL 208

14 19-Nov-19 182080820006 PATEL DHWANIBAHEN ARVINDBHAI MRW304P 20 208 MP PharmaceuticsVESICULAR DRUG

DELIVERY SYSTEM

NANOEMULSION BASED NOSE TO BRAIN DELIVERY OF

DOLUTEGRAVIR.DR. SUNITA CHAUDHARY 208

15 19-Nov-19 182080820007 PATEL DRASHTI INDRAVADANBHAI MRW304P 20 208 MP PharmaceuticsVESICULAR DRUG

DELIVERY SYSTEM

PREPARATION AND CHARACTERIZATION OF

DEXIBUPROFEN SUSPENSION FOR INTRAMUSCULAR

DEPOT THERAPY.

DR. UPENDRA L. PATEL 208

16 19-Nov-19 182080820009 SHARMA ASHUTOSH MUNESHCHANDRA MRW304P 20 208 MP Pharmaceutics OTHER (KINDLY SPECIFY) TEST MASKING FORMULATION AND EVALUATION OF TASTE MASKED DRY

SYRUP OF CEFUROXIME AXETIL.DR. DASHARATH M. PATEL 208

17 19-Nov-19 182080824002 KOTHARI DHRUV HARIKRUSHNBHAI MRW304P 24 208 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

DEVELOPMENT AND VALIDATION OF STABILITY

INDICATING HPTLC METHOD FOR SIMULTANEOUS

ESTIMATION OF AMLODIPINE BESYLATE AND CELECOXIB IN


DR JIGNASHA DERASARI 208

Gujarat Technological University

Student list for M.Pharm Sem 3 (Regular) Dissertation Phase-1 Exam (Winter 2019)GTU/W19/DP-1/MPH-3213/12167 Date:- 11/11/2019

18 19-Nov-19 182080824006 PATEL NIDHI DINESHKUMAR MRW304P 24 208 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


AND VALIDATION OF FEBUXOSTAT IN TABLET DOSAGE

FORM

MR. HIREN KADIKAR 208

19 19-Nov-19 182080824005 PATEL HIMANIBEN MANISHBHAI MRW304P 24 208 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


AND VALIDATION OF NEFOPAM HYDROCHLORIDE IN

TABLET DOSAGE FORM

MS. MONA CHRISTIAN 208

20 19-Nov-19 182080824010 SHAH JAINA VIPULBHAI MRW304P 24 208 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


AND VALIDATION OF AMINOCAPROIC ACID IN


MR. HIREN KADIKAR 208

21 19-Nov-19 182080824012 SHAILY SANJAYKUMAR MODI MRW304P 24 208 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


AND VALIDATION OF ERTUGLIFLOZIN IN PHARMACEUTICAL

DOSAGE FORM


22 19-Nov-19 182080824003 MIRAL DOSI MRW304P 24 208 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


CARGLUMIC ACID IN PHARMACEUTICAL DOSAGE FORM DR. NISHA PARIKH 208

23 19-Nov-19 182080824004 Patel foram pareshkumar MRW304P 24 208 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF

SIMULTANEOUS ESTIMATION OF DORAVIRINE,

LAMIVUDINE AND TENOFOVIR DISPROXIL FUMARATE IN


DR. JITENDRA S PATEL 208

24 19-Nov-19 182080824007 PATEL SHIVANGINI ASHWINKUMAR MRW304P 24 208 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

HPTLC METHOD DEVELOPMENT AND VALIDATION OF

CARICA PAPAYA L. LEAF EXTRACT IN TABLET DOSAGE

FORM


25 19-Nov-19 182080824009 SHAH CHARMI DIPAKKUMAR MRW304P 24 208 MPPharmaceutical

Quality

Assurance

IMPURITY PROFILING


APREMILAST AND ITS RELATED SUBSTANCES IN TABLET

DOSAGE FORM BY RP-HPLC

DR. JITENDRA PATEL 208

26 19-Nov-19 182080824011 Shah Rajvi Nikhil MRW304P 24 208 MPPharmaceutical

Quality

Assurance

IMPURITY PROFILING

IDENTIFICATION, SEPARATION, ISOLATION AND

CHARACTERIZATION OF POTENTIAL IMPURITY OF

EMPAGLIFLOZIN

DR. NISHA PARIKH 208

27 19-Nov-19 182080824001 AANCHAL JAIN MRW304P 24 208 MPPharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY)SYNTHESIS OF

BIOCONJUGATES

SYNTHESIS, CHARACTERIZATION AND SCREENING OF

NOVEL ANTIBIOTIC BIOCONJUGATESDR. NISHA PARIKH 208

28 19-Nov-19 182080824008 SHAH AAYESHA ABHAYKUMAR MRW304P 24 208 MPPharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY)

SYNTHESIS OF

STATIN

CONJUGATES

SYNTHESIS, CHARACTERIZATION AND DETERMINATION OF

PHYSICOCHEMICAL PROPERTIES OF NOVEL STATIN

CONJUGATES

DR. JIGNASHA DERASARI 208

29 19-Nov-19 182240820001 Parmar Gaurangkumar Pankajbhai MRW304P 20 224 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF IMMEDIATE RELEASE

TABLETS OF EMPAGLIFLOZINMRS SEJAL M SOLANKI 224

30 19-Nov-19 182240820002 Patel Nihalkumar Mukeshbhai MRW304P 20 224 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


MATRIX TABLETS OF RIVAROXABANMR JAYANTI V BAJAG 224

31 19-Nov-19 182240820003 Vaghela Meghana Rameshbhai MRW304P 20 224 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF FAST DISSOLVING

TABLETS OF BLONANSERINMRS SEJAL M SOLANKI 224

32 19-Nov-19 182280820007 SHAH ANOKHI MRW304P 20 228 MP Pharmaceutics


FAST


DESIGN, DEVELOPMENT AND EVALUATION OF

SUBLINGUAL FILMS CONTAINING SELECTED ANTI-

MUSCARINIC AGENT

DR. PRAFUL D. BHARADIA 228

33 19-Nov-19 182280820008 SHAH STUTEE NIMESHBHAI MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION, OPTIMIZATION AND EVALUATION OF

SUBLINGUAL FILMS OF AN ANTI-HYPERTENSIVE AGENTDR. PRAFUL D. BHARADIA 228

34 19-Nov-19 182280820009 Shah Vatsal Rakeshbhai MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION, DEVELOPMENT AND EVALUATION OF

SUBLINGUAL TABLETS OF ANTI-HISTAMINIC AGENTDR. YAMINI D. SHAH 228

35 19-Nov-19 182280820010 vachheta dolly nareshbhai MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION, DEVELOPMENT AND EVALUATION OF

SUBLINGUAL TABLETS OF ANTI-SPASMODIC AGENTDR. YAMINI D. SHAH 228

36 19-Nov-19 182280820001 ANKIT KOUL MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION DEVELOPMENT AND EVALUATION OF

SUBLINGUAL TABLETS OF SELECTED ANTI COAGULANT

AGENT.


37 19-Nov-19 182280820002 JETHA KESHAVA LAKSHMINARAYAN MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION DEVELOPMENT AND EVALUATION OF ORAL

TRANS-MUCOSAL DELIVERY SYSTEM OF ALFUZOSIN

HYDROCHLORIDE FOR TREATMENT OF BENIGN PROSTATIC

HYPERPLASIA.


38 19-Nov-19 182280820003 MAKWANA BRINDA RATNASINH MRW304P 20 228 MP Pharmaceutics


FAST


FORMULATION,DEVELOPMENT AND EVALUATION OF ORAL

TRANSMUCOSAL DELIVERY SYSTEM OF ANTI-DEPRESSANT

AGENT

DR. RADHIKA B. PANDYA 228

39 19-Nov-19 182280820004 PATEL NIDHI HARSHADBHAI MRW304P 20 228 MP Pharmaceutics


FAST



SUBLINGUAL TABLETS OF BETA-BLOCKING AGENTDR. MANISH P. PATEL 228

40 19-Nov-19 182280820005 PRAJAPATI HIMALI JAYENDRABHAI MRW304P 20 228 MP Pharmaceutics


FAST



RAPID MOUTH DISSOLVING TABLETS OF ANTI-

HYPERTENSIVE AGENT.

DR. MANISH P. PATEL 228

41 19-Nov-19 182280820006 RUPANI HETANSH PARESHBHAI MRW304P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)DISSOLUTION

ENHANCEMENT

DISSOLUTION ENHANCEMENT OF BILASTINE USING

DIFFERENT TECHNIQUES.DR. MANISH P. PATEL 228

42 19-Nov-19 182280824001 KATARIA JAHANVIBEN ANILKUMAR MRW304P 24 228 MPPharmaceutical

Quality

Assurance

HERBAL

FORMULATION AND STANDARDIZATION OF A

PHYTOPHARMACEUTICAL PRODUCT OF PIPER LONGUM

WITH ANTI-HYPERLIPIDEMIC ACTIVITY

DR. JAYANT B. DAVE 228

43 19-Nov-19 182280824002NAVLIWALA MOHAMMADHASIL

ABDULSAMADMRW304P 24 228 MP

Pharmaceutical

Quality

Assurance


ANALYTICAL

METHOD

DEVELOPMENT

AND VALIDATION

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD

FOR ESTIMATION OF REMOGLIFLOZIN ETABONATE IN ITS

TABLET DOSAGE FORMS

DR. DR. SINDHU B EZHAVA 228

44 19-Nov-19 182280824007 SHETH PRACHI KETANKUMAR MRW304P 24 228 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

FOR THE SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN

HYDROCHLORIDE AND LOTEPREDNOL ETABONATE IN

OPHTHALMIC DOSAGE FORM

DR. ANURADHA K. GAJJAR 228

45 19-Nov-19 182280824008 SURI RUCHITA HARISHCHANDRA MRW304P 24 228 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR ESTIMATION OF METFORMIN HYDROCHLORIDE,

DAPAGLIFLOZIN PROPANEDIOL AND SAXAGLIPTIN

HYDROCHLORIDE IN FIXED DOSE COMBINATION

DR. SINDHU EZHAVA 228

46 19-Nov-19 182280824006 RANA PINAL MAHENDRAKUMAR MRW304P 24 228 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR

ESTIMATION OF OFLOXACIN, TINIDAZOLE, TERBINAFINE

HYDROCHLORIDE AND CLOBETASOL PROPIONATE IN

TOPICAL FORMULATION

DR. KUNJAN BODIWALA 228

47 19-Nov-19 182280824003 Panchal Bhoomi Ghanshyambhai MRW304P 24 228 MP

Pharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY)IMPURITY

ANALYSIS

DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC

METHOD FOR ESTIMATION OF NITROSAMINE IMPURITIES

IN SELECTED PHARMACEUTICAL SUBSTANCES

DR. KUNJAN BODIWALA 228

48 19-Nov-19 182280824005 PRAJAPATI PRITI KALPESH MRW304P 24 228 MP

Pharmaceutical

Quality

Assurance


STABILITY

INDICATING ASSAY

METHOD

DEVELOPMENT AND VALIDATION OF UV

SPECTROPHOTOMETRIC AND STABILITY INDICATING

CHROMATOGRAPHIC METHODS FOR THE ESTIMATION OF

EVOGLIPTIN TARTRATE IN DOSAGE FORMS

DR. ANURADHA K. GAJJAR 228

49 19-Nov-19 182420820001 MAKVANA GIRISHKUMAR BHIKHBHAI MRW304P 20 242 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF BUCCAL TABLETS OF

BUSPIRONE HYDROCHLORIDE DR DHAVAL J. PATEL 242

50 19-Nov-19 182420820002 MODI JAYKUMAR KAMLESHBHAI MRW304P 20 242 MP Pharmaceutics


FAST


FORMULATION AND CHARACTERISATION OF

CHLORTHALIDONE LIQUISOLID COMPACTSDR S K SHAH 242

51 19-Nov-19 182420820003 PATEL SURESHBHAI KUBERBHAI MRW304P 20 242 MP Pharmaceutics


FAST


FORMULATION AND OPTIMIZATION OF STABLE NON-

AQUEOUS SOLUTION OF DOXYCYCLINE HYCLATE.DR DHAVAL J PATEL 242

52 19-Nov-19 182420820005 SHAH RAHUL VINAYKUMAR MRW304P 20 242 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF OXYBUTYNIN

CHLORIDE OSMOTICALLY CONTROLLED RELEASE TABLETS.DR DHAVAL J PATEL 242

53 19-Nov-19 182420820006 SHAH RAJ NITINKUMAR MRW304P 20 242 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF GASTRORETENTIVE

FLOATING IN SITU GEL OF FEBUXOSTATDR S K SHAH 242

54 19-Nov-19 182420820008 SHUKLA BHRANTI BHASKARBHAI MRW304P 20 242 MP Pharmaceutics


FAST


PHYSICOCHEMICAL CHARACTERIZATION AND

DISSOLUTION ENHANCEMENT OF MACITENTAN BY SOLID

DISPERSION TECHNIQUE

DR DHAVAL J PATEL 242

55 19-Nov-19 182420820009 YADAV POONAM SURESHBHAI MRW304P 20 242 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF STOMACH SPECIFIC

FLOATING TABLETS OF ELUXADOLINE.DR SANJESH G. RATHI 242

56 19-Nov-19 182420820010 ZALA SEJALKUMARI ARJUNSINH MRW304P 20 242 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SPHERICAL CRYSTAL

AGGLOMERATES OF LURASIDONE HYDROCHLORIDE. DR SANJESH G RATHI 242

57 19-Nov-19 182600820001 GODHA JIGAR GUNVANTBHAI MRW304P 20 260 MP Pharmaceutics


FAST


FORMULATION & STABILIZATION OF ORAL SOLID DOSAGE

FORM OF AMINE CONTAINING DRUG HAVING CARDIO

SELECTIVE BETA ADRENERGIC BLOCKING ACTIVITY

MR. HARSH J. TRIVEDI 260

58 19-Nov-19 182600820003 KATHIRIYA BHAGAVATIBEN VIPULBHAI MRW304P 20 260 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN AND EVALUATION OF ONCE DAILY EXTENDED

RELEASE TABLETS OF ANTIEPILEPTIC DRUGDR. KUNAL N. PATEL 260

59 19-Nov-19 182600820006 YADAV VIPIN THANSINGH MRW304P 20 260 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


NATURAL POLYMER BASED TABLETS FOR EXTENDED

RELEASE OF FLUVOXAMINE MALEATE

MRS. BHAVANA A. PATEL 260

60 19-Nov-19 182620820001 ANSARI GAZALA MOHAMMEDYUSUFBHAI MRW304P 20 262 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF RAPID

DISINTEGRATING TABLETS OF AN ANTI-PSYCHOTIC DRUGMR. SURAJ R. CHAUHAN 262

61 19-Nov-19 182620820002 JAT MANJITSINGH NANURAM MRW304P 20 262 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT AND CHARACTERIZATION OF SUSTAINED

MATRIX TABLETS OF VILDAGLIPTINPROF. RAVI V. PATEL 262

62 19-Nov-19 182620820003 QURESHI NADEEM NAJIRMAHAMMAD MRW304P 20 262 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF ORAL

DISINTEGRATING FILM OF SITAGLIPTIN PHOSPHATEMS. BHUMI A. RAVAL 262

63 19-Nov-19 182620820004 VASOYA VISHALBHAI BHARATBHAI MRW304P 20 262 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF ORAL

DISINTEGRATING STRIP OF IVABRADINE HYDROCHLORIDEPROF. RAVI V. PATEL 262

64 19-Nov-19 182620824002CHANDALAWALA CHITRANGI

PARESHKUMARMRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING ANALYTICAL METHOD

DEVELOPMENT AND VALIDATION FOR THE

SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

65 19-Nov-19 182620824004 LIMBACHIYA PARESHKUMAR BALDEVBHAI MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



SIMULTANEOUS ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

66 19-Nov-19 182620824005 MISHRA SWETAKUMARI HARSHNATH MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM

AND ROSUVASTATIN CALCIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

67 19-Nov-19 182620824006 PADHERIYA MAITRI DILAVARSINGH MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



SIMULTANEOUS ESTIMATION OF LISINOPRIL AND

LOSARTAN POTASSIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

68 19-Nov-19 182620824012 SABALPARA DIVYA JAYANTILAL MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND


DR. JITENDRA O.

BHANGALE262

69 19-Nov-19 182620824001 BACHCHHAV SHWETA KAILASH MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND


DR. JITENDRA O.

BHANGALE262

70 19-Nov-19 182620824003 LIMANI GUNJAN NARENDRAKUMAR MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND

FENOFIBRATE IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

71 19-Nov-19 182620824008 Patel Hinal Chhotubhai MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

METHOD DEVELOPMENT AND VALIDATION OF

BETAMETHASONE SODIUM PHOSPHATE AND

BETAMETHASONE ACETATE IN PHARMACEUTICAL DOSAGE

FORM BY RP-HPLC METHOD

DR. JITENDRA O.

BHANGALE262

72 19-Nov-19 182620824013 SHAH RIYABEN PRAKASHKUMAR MRW304P 24 262 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF FOSINOPRIL SODIUM

AND PRAVASTATIN SODIUM IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE262

73 19-Nov-19 182620824009 PATEL MRUGANK HEMENDRA MRW304P 24 262 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF OCTREOTIDE

ACETATE INJECTABLE SUSPENSION

DR. JITENDRA O.

BHANGALE262

74 20-Nov-19 182070820004 NIHAL CHANDNIWALA MRW304P 20 207 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF LULICONAZOLE

TOPICAL FILM-FORMING SPRAYDR. VISHNU M. PATEL 207

75 20-Nov-19 182070820005 RAJEBHAI FAYEJABANU SIRAJAHMED MRW304P 20 207 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF MUCOADHESIVE

BUCCAL DRUG DELIVERY OF ITRACONAZOLE FOR ORAL

CANDIDIASIS

DR. VISHNU M. PATEL 207

76 20-Nov-19 182070820003 NADIYA SAPANABEN RAJESHBHAI MRW304P 20 207 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

PREPARATION AND EVALUATION OF OPHTHALMIC IN-SITU

GEL OF ITRACONAZOLEDR ANAND K PATEL 207

77 20-Nov-19 182070820001 BHATT KRUTIBAHEN INDRAVADANBHAI MRW304P 20 207 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

PREPARATION AND EVALUATION OF GASTRORETENTIVE IN-

SITU GEL OF SUCRALFATE AND OXETACAINEDR ANAND K PATEL 207

78 20-Nov-19 182230828001 PATEL RIDDHIBEN RAMESHCHANDRA MRW304P 28 223 MPPharmaceutical

Technology

NANO

SUSPENSION/EMULSION,

SEDDS, LIPID BASED DDS

DEVELOPMENT AND CHARACTERIZATION OF

NANOEMULSION FOR INTRANASAL DELIVERY OF

LURASIDONE HYDROCHLORIDE

DR. ALIASGAR J

KUNDAWALA223

79 20-Nov-19 182230828002 SHAH DHWANI MANISHKUMAR MRW304P 28 223 MPPharmaceutical

Technology

NANO



DEVELOPMENT AND CHARACTERIZATION OF DRY POWDER

CONTAINING ROFLUMILAST PREPARED BY FREEZE DRYING

METHOD

DR. ALIASGAR J

KUNDAWALA223

80 20-Nov-19 182250820003 PATEL MAHESHWARI GHANSHYAMBHAI MRW304P 20 225 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILMS

OF CARVEDILOLDR. KEYUR S. PATEL 225

81 20-Nov-19 182250820001 KHARADI PIYUSHKUMAR JAYSINGBHAI MRW304P 20 225 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SUBLINGUAL FILMS

OF APIXABANDR.SHAILESH T.PRAJAPATI 225

82 20-Nov-19 182250820002 PATEL DHRUVIL SHAILESHKUMAR MRW304P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF DELAYED RELEASE

TABLETS OF IVABRADINE HYDROCHLORIDE DR. SHAILESH T. PRAJAPATI 225

83 20-Nov-19 182250820004 RAO AKSHAR NIKHILESHKUMAR MRW304P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF FLOATING TABLETS

OF QUETIAPINE FUMARATEDR. KEYUR S. PATEL 225

84 20-Nov-19 182250820005 THAKOR NILESHKUMAR MANKAJI MRW304P 20 225 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SUBLINGUAL

TABLETS OF CLOMIPRAMINE HYDROCHLORIDEDR. ZIL PATEL 225

85 20-Nov-19 182250824001 ASODIYA AXEN KIRIT MRW304P 24 225 MPPharmaceutical

Quality

Assurance

STABILITY STUDIESSTABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF SELINEXOR IN TABLETDR. SAMIR C. PATEL 225

86 20-Nov-19 182250824002 CHAUHAN BHAVESHKUMAR KHANABHAI MRW304P 24 225 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF BREMELANOTIDE IN

INJECTION

DR. SAMIR C. PATEL 225

87 20-Nov-19 182250824003 PATEL JANKHANABEN DINESHBHAI MRW304P 24 225 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


DEVELOPMENT AND VALIDATION OF DOLUTEGRAVIR AND

LAMIVUDINE IN TABLET

DR. DEEPA R. PATEL 225

88 20-Nov-19 182250824005 PATEL USHMABEN BABUBHAI MRW304P 24 225 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


DEVELOPMENT AND VALIDATION OF REMOGLIFLOZIN IN

TABLET


89 20-Nov-19 182250824007 PRAJAPATI UTTAM MAGANLAL MRW304P 24 225 MPPharmaceutical

Quality

Assurance

STABILITY STUDIESSTABILITY INDICATING CHROMATOGRAPHIC METHOD

DEVELOPMENT AND VALIDATION OF ALPELISIB IN TABLETDR. DEEPA R. PATEL 225

90 20-Nov-19 182250824004 PATEL RIPALBEN DINESHBHAI MRW304P 24 225 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN,

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE IN

TABLET


91 20-Nov-19 182250824006 PRAJAPATI HIMANI RAMESHBHAI MRW304P 24 225 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF HALOBETASOL AND

TANZOROTENE IN LOTION


92 20-Nov-19 182250824008 RATHOD URVISHA RANJITBHAI MRW304P 24 225 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF ALCAFTADINE AND

KETOROLAC TROMETHAMINE IN EYE DROPS


93 20-Nov-19 182420820007 SHARMA PANKAJKUMAR GORAKHNATH MRW304P 20 242 MP Pharmaceutics

NANO



DEVELOPMENT AND OPTIMIZATION OF LOTEPREDNOL

ETABONATE LOADED IN OPTHALMIC NANOGELDR S K SHAH 242

94 20-Nov-19 182470820004 Patel Rima Sureshbhai MRW304P 20 247 MP Pharmaceutics MISCELANEOUSFORMULATION AND CHARACTERIZATION OF LIQUISOLID

COMPACTS OF CILOSTAZOL.MR. VIJAY PATEL 247

95 20-Nov-19 182470820001 ADHYARU PARTH GAUTAMKUMAR MRW304P 20 247 MP Pharmaceutics OTHER (KINDLY SPECIFY) CHEWABLE TABLETFORMULATION, DEVELOPMENT AND EVALUATION OF

CHEWABLE TABLETS OF NEBIVOLOL HCLDR. YOGESH PATEL 247

96 20-Nov-19 182470820002 PATEL DHAVAL ASHISHBHAI MRW304P 20 247 MP Pharmaceutics


FAST



SUBLINGUAL FILM OF CYANOCOBALAMIN.MR. ANIL G. RAVAL 247

97 20-Nov-19 182470820003 PATEL PRACHI RAJENDRAKUMAR MRW304P 20 247 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF ORALLY

DISINTEGRATING FILMS OF DEXTROMETHORPHAN

HYDROBROMIDE USING QUALITY BY DESIGN APPROACH.

DR. DHARA PATEL 247

98 20-Nov-19 182470824002 GOHEL VRUSHIKA RANJITSINH MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF HALOBETASOL PROPIONATE AND

TAZAROTENE IN SYNTHETIC MIXTURE.

MS.KUNJAL VEGAD 247

99 20-Nov-19 182470824003 JAGIRDAR DAYAWATI ANANTKUMAR MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF

PEXIDARTINIB IN BULK AND PHARMACEUTICAL DOSAGE

FORM

MS.DHWANI SHAH 247

100 20-Nov-19 182470824004 PAEL RAJARSHREE KETANBHAI MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF KETOROLAC TROMETHAMINE AND

ALCAFTADINE IN SYNTHETIC MIXTURE.

MR.KAUSHIK PATEL 247

101 20-Nov-19 182470824005 PANCHAL KRISHNA BHARATBHAI MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF

REMOGLIFILOZIN BY HPLC IN BULK AND PHARMACEUTICAL

DOSAGE FORMS.

KAUSHIK PATEL 247

102 20-Nov-19 182470824007 PATEL BHOOMI VIJAYBHAI MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING METHOD DEVELOPMENT AND

VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

LESINURAD AND ALLOPURINOL BY HPLC IN BULK AND

PHARMACEUTICAL DOSAGE FORMS.

JAYMIN.G.PATEL 247

103 20-Nov-19 182470824009 PATEL DHRUVINABEN MANOJKUMAR MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


STABILITY INDICATING RP-HPLC METHOD FOR

SIMULTANEOUS ESTIMATION OF ACLIDINIUM BROMIDE

AND FORMOTEROL FUMARATE IN SYNTHETIC MIXTURE.

MR. JAYMIN G PATEL 247

104 20-Nov-19 182470824010 PATEL MAITRIBAHEN JAYANTIBHAI MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


FOR THE SIMULTANEOUS ESTIMATION OF

DOLUTEGRAVIR,EMTRICITABINE AND TENOFOVIR

ALAFENAMIDE BY HPLC IN BULK PHARMACEUTICAL

DOSAGE FORM.

MS.ANKITA PATEL 247

105 20-Nov-19 182470824011 PATEL MANALIBEN SUNILBHAI MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

BIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT, METHOD

VALIDATION AND STABILITY FOR ESTIMATION OF

CHLORTHALIDONE IN HUMAN PLASMA BY USING LC-ESI-

MS/MS

MR. JAYMIN G PATEL 247

106 20-Nov-19 182470824013 SONI POOJA HARESHKUMAR MRW304P 24 247 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF

ROSUVASTATIN AND VITAMIN D3 BY HPLC IN BULK AND


DR.VINAY DARJI 247

107 20-Nov-19 182520820002 KADIYA PARTH DILIPKUMAR MRW304P 20 252 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

DEVELOPMENT OF NEW MULTIPURPOSE DIRECTLY

COMPRESSIBLE CO-PROCESSED EXCIPIENT FOR TABLET

FORMULATIONS

SANJAYKUMAR S PATEL 252

108 20-Nov-19 182520820006 PATEL VIMALKUMAR BIPINBHAI MRW304P 20 252 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

DEVELOPMENT OF NOVEL DIRECTLY COMPRESSIBLE CO-

PROCESSED ADJUVANT FOR CHEWABLE TABLETSANJAYKUMAR S PATEL 252

109 20-Nov-19 182520820003 KHAN SALAUDDIN MD OSAMA MRW304P 20 252 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN, DEVELOPMENT AND OPTIMISATION OF

FEBUXOSTAT TRANSDERMAL PATCHDR MAULIK R MEHTA 252

110 20-Nov-19 182520820001 ACHARYA AMIRAS RAJNIKANT MRW304P 20 252 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN AND DEVELOPMENT OF APREMILAST SUSTAINED

RELEASE TABLETDR ALPESHBHAI D PATEL 252

111 20-Nov-19 182520820005 PATEL MANESHKUMAR AMRUTLAL MRW304P 20 252 MP Pharmaceutics


FAST


DESIGN AND DEVELOPMENT OF ORODISPERSIBLE FILM OF

LAMOTRIGINEDR MAULIKKUMAR J PATEL 252

112 20-Nov-19 182520820004 PATEL AFIKA JAKIRHUSEN MRW304P 20 252 MP Pharmaceutics


FAST


FORMULATION AND CHARACTERIZATION OF

BLONANSERIN TABLET USING LIQUID SOLID TECHNIQUEDR MAULIK R MEHTA 252

113 20-Nov-19 182600820005SHAIKH MOHAMMEDMUJAMMIL

JAKIRHUSENMRW304P 20 260 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND OPTIMIZATION OF MULTIPLE UNIT

PELLET SYSTEM (MUPS) OF MESALAMINE USING

EXTRUSION-SPHERONIZATION TECHNIQUE

DR. KUNAL N. PATEL 260

114 20-Nov-19 182600820002 GUPTA MONIKA ASHOKKUMAR MRW304P 20 260 MP Pharmaceutics

NANO



DEVELOPMENT AND CHARACTERIZATION OF SELF

EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF

UBIDECARENONE FOR ENHANCING SOLUBILITY AND

STABILITY


115 20-Nov-19 182600820004 PATEL PRUTHA KARTIK MRW304P 20 260 MP Pharmaceutics OTHER (KINDLY SPECIFY)PULSATILE DRUG

DELIVERY SYSTEM

DEVELOPMENT AND OPTIMIZATION OF PRESS-COATED

TABLETS FOR TREATMENT OF NOCTURNAL BRONCHIAL

ASTHMA


116 20-Nov-19 182600824002 JIVANI VISHWA ARVINDKUMAR MRW304P 24 260 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING RP-HPLC METHOD FOR TENOFOVIR

DISOPROXIL FUMARATE AND ITS IMPURITIES IN


MS. VANITA H.

MARVANIYA260

117 20-Nov-19 182600824003 PANCHAL HITAISHI JAGDISHKUMAR MRW304P 24 260 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING ASSAY METHOD FOR THE ESTIMATION OF

TOFACITINIB IN TOFACITINIB EXTENDED RELEASE TABLETS

DR. CHIRAG J. PATEL 260

118 20-Nov-19 182600824005 SHAH BIJAL JITENDRAKUMAR MRW304P 24 260 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING


ELEMENTAL IMPURITIES OF AMINOCAPROIC ACID TABLETS

AND POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

BY INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY

(ICP-MS)


119 20-Nov-19 182600824004 PATEL SHRADDHABEN JAYESHKUMAR MRW304P 24 260 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING ASSAY RP-HPLC METHOD FOR OCTREOTIDE

ACETATE FOR INJECTABLE SUSPENSION


120 20-Nov-19 182600824006 YADAV MEENAKSHI MAHESHKUMAR MRW304P 24 260 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING RP-HPLC METHOD FOR TICLOPIDINE

HYDROCHLORIDE AND ITS IMPURITIES IN


MS. VANITA H.

MARVANIYA260

121 20-Nov-19 182780820001 PILLAI ARCHANA ANIL MRW304P 20 278 MP Pharmaceutics


FAST



TABLETS OF FEBUXOSTAT.DR.KINJAL P. SOLANKI 278

122 20-Nov-19 182780820002 Purohit Kusum Shankarsinh MRW304P 20 278 MP Pharmaceutics


FAST


FORMULATION EVALUATION AND OPTIMIZATION OF

ORODISPERSIBLE FILMS OF NEBIVOLOL HYDROCHLORIDE.DR.VIKRAM PANDYA 278

123 20-Nov-19 182780820003 YADAV DIMPLE SHYAMKUMAR MRW304P 20 278 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SUBLINGUAL

TABLETS OF CINNARIZINE.MS.JIMMY M.LIMBACHIYA 278

124 20-Nov-19 182780824002 NINAMA NITAKUMARI BACHUBHAI MRW304P 24 278 MPPharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY)METHOD

DEVELOPMENT

RP-HPLC METHOD DEVLOPMENT AND VALIDATION FOR

THE ESTIMATION OF FEDRATINIB IN PHARMACEUTICAL

DOSAGE FORM

DR SANDIP DHOLAKIA 278

125 20-Nov-19 182780824003 PATEL MANSI MUKESHKUMAR MRW304P 24 278 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING RP-HPLC METHOD FOR THE ESTIMATION OF

REMOGLIFLOZIN ETABONATE IN ITS TABLET DOSAGE

FORM

DR RAJESH PATEL 278

126 20-Nov-19 182780824001 HINGU JAGRUTI CHHAGANLAL MRW304P 24 278 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



ENTRECTINIB IN PHARMACEUTICAL DOSAGE FORM.

MS. DARPINI PATEL 278

127 20-Nov-19 182860820003 GOSWAMI SIDDHARTH MRW304P 20 286 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION DEVELOPMENT & EVALUATION OF KOJIC

ACID NANOFIBRE FOR TOPICAL DELIVERYDR. NISHITH PATEL 286

128 20-Nov-19 182860820002 GAJJAR PINALBEN JITENDRABHAI MRW304P 20 286 MP Pharmaceutics

NANO



FORMULATION, DEVELOPMENT AND CHARACTERIZATION

OF PALIPERIDONE LOADED NANOSTRUCTURED LIPID

CARRIER

MR.KRUNAL DETHOLIA 286

129 20-Nov-19 182860820004 KHATRI RITIKSHA SUNILKUMAR MRW304P 20 286 MP Pharmaceutics

NANO



FABRICATION AND OPTIMIZATION OF FEBUXOSTAT

LOADED NANOSTRUCTURED LIPID CARRIER BY 32 FULL

FACTORIAL DESIGN

MR. UMANG VARIA 286

130 20-Nov-19 182860820007 SHAH HARSH KAMLESHKUMAR MRW304P 20 286 MP Pharmaceutics

NANO



FORMULATION DEVELOPMENT AND CHARACTERIZATION

OF LEVOSULPIRIDE NANOLIPID CARRIERDR. NISHITH PATEL 286

131 20-Nov-19 182860820005 PATEL SHIVANI PRAKASHKUMAR MRW304P 20 286 MP Pharmaceutics OTHER (KINDLY SPECIFY) ANN

DEVELOPMENT OF ARTIFICAL NEURAL NETWORK FOR SR

MONOLITHIC TABLETS USING DISCRIMINATIVE

DISSOLUTION TEST METHOD

MR.KRUNAL DETHOLIA 286

132 20-Nov-19 182860820006 PRAJAPATI MANISH PRABHUDAS MRW304P 20 286 MP Pharmaceutics MULTIPARTICULATE

DEVELOPMENT AND CHARACTERIZATION OF POLYMERIC

IDEBENONE SPHERICAL CRYSTALS BY EMULSION SOLVENT

DIFFUSION TECHNIQUE FOR SOLUBILITY ENHANCEMENT

MR. UMANG VARIA 286

133 20-Nov-19 182860824002 CHANDEKAR YOJANA MADHUKAR MRW304P 24 286 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING RP-HPLC METHOD FOR ESTIMATION OF

FLUCLOXACILLIN SODIUM IN TABLET DOSAGE FORM

MS. MINAKSHI M. DHORU 286

134 20-Nov-19 182860824003 KURMI AMBIKA JANARDAN MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING HPTLC METHOD FOR ESTIMATION OF

MIRABEGRON FROM ITS PHARMACEUTICAL

FORMULATION.

MRS. BINNY D. MEHTA 286

135 20-Nov-19 182860824004 KUSHAWAHA SUNITA KAMALDEVSINGH MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



RIVAROXABAN AND ASPIRIN FROM SYNTHETIC MIXTURE.

DR. PINAK R. PATEL 286

136 20-Nov-19 182860824013 YADAV VARSHA RAMKUMAR MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



CELECOXIB AND AMLODIPINE FROM SYTHETIC MIXTURE.


137 20-Nov-19 182860824001 BHATT JIGNA HEMANTKUMAR MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF ANALYTICAL

METHODS FOR DETERMINATION OF AMLODIPINE

BESYLATE, ROSUVASTATIN CALCIUM AND TELMISARTAN

FROM SYNTHETIC MIXTURE


138 20-Nov-19 182860824007 PANJABI RESHMA MURLIDHAR MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF SAXAGLIPTIN,

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE BY

HPLC IN TABLET DOSAGE FORM


139 20-Nov-19 182860824008 PATEL HETALBEN MULJIBHAI MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR THE SIMULTANEOUS ESTIMATION OF KETOROLAC

TROMETHAMINE AND ALCAFTADINE BY RP-HPLC FROM ITS

PHARMACEUTICAL DOSAGE FORM.


140 20-Nov-19 182860824009 PATEL JAY RAJESHBHAI MRW304P 24 286 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR DETERMINATION OF PREDNISOLONE AND

ASPIRIN FROM SYNTHETIC MIXTURE.


141 20-Nov-19 182860824010 PATEL KHUSHBUKUMARI GUNVANTBHAI MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF HALOBETASOL

PROPIONATE AND TAZAROTENE BY HPLC FROM LOTION

DR. MANDEV B. PATEL 286

142 20-Nov-19 182860824012 PATEL PRIYANSHI MEHULBHAI MRW304P 24 286 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHOD FOR QUANTIFICATION OF FENTICONAZOLE

NITRATE AND ITS RELATED SUBSTANCES FROM SOFT

GELATIN CAPSULE DOSAGE FORM


143 20-Nov-19 182860824006 PANCHAL RIMABAHEN YOGESHBHAI MRW304P 24 286 MPPharmaceutical

Quality

Assurance

PROCESS VALIDATIONPROCESS VALIDATION OF OPTIMIZED FORMULATION OF

VILDAGLIPTIN TABLET DOSAGE FORMDR. MANDEV B. PATEL 286

144 21-Nov-19 182020820001 PATEL KRUPALI SHAILESHKUMAR MRW304P 20 202 MP Pharmaceutics OTHER (KINDLY SPECIFY)

NANOPARTICLES

LOADED BUCCAL

FILMS

DESIGN AND IN VITRO CHARACTERIZATION OF

NANOPARTICLES LOADED BUCCAL FILMS: AN ATTEMPT TO

ENHANCE BIOAVAILABILITY OF NIMODIPINE

DR. SAIKAT PANDE 202

145 21-Nov-19 182020820002 SHALINI DWIVEDI MRW304P 20 202 MP Pharmaceutics

NANO



DEVELOPMENT, IN-VITRO CHARACTERIZATION AND

OPTIMIZATION OF OLMESARTAN MEDOXOMIL LOADED

SNEDDS: AN ADVENT FOR ENHANCEMENT OF

BIOAVAILABILITY

DR. AJAY B. SOLANKI 202

146 21-Nov-19 182020824002 PATEL CHANDNI SAMIRBHAI MRW304P 24 202 MP

Pharmaceutical

Quality

Assurance


ANALYTICAL

METHOD

DEVELOPMENT



DAPAGLIFLOZIN PROPANEDIOL AND SAXAGLIPTIN

HYDROCHLORIDE DIHYDRATE IN BULK AND TABLET

DOSAGE FORM

DR.(MRS)

ANANDKUMARI.D.CAPTAIN202

147 21-Nov-19 182020824001 VASANI MEGHA VIRENDRAKUMAR MRW304P 24 202 MP

Pharmaceutical

Quality

Assurance


ANALYTICAL

METHOD

DEVELOPMENT


INDICATING HPTLC METHOD FOR LORCASERIN

HYDROCHLORIDE HEMIHYDRATE IN BULK AND TABLET

DOSAGE FORM

DR.RAJENDRAKUMAR.S.M

EHTA202

148 21-Nov-19 182050820011 VAHORA MOHAMMAD TALHA MUSTUFA MRW304P 20 205 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

SYSTEMIC DEVELOPMENT OF TOPICAL VALSARTAN

WOUND CARE FORMULATIONDR. VAISHALI T. THAKKAR 205

149 21-Nov-19 182050820006 Pankaj Kumar MRW304P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

MICROWAVE ASSISTED SOLID DISPERSION TECHNIQUE:

QUICK AND EFFICIENT METHOD TO ENHANCE

DISSOLUTION OF CILOSTAZOL

DR.CHETNA D. MODI 205

150 21-Nov-19 182050820010RAULJI JAYVANTIKAKUNVERBA

DHARMPALSINHMRW304P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

STUDIES IN THE DEVELOPMENT OF SOLID ORAL DOSAGE

FORM USING INTRAGRANULAR AND EXTRAGRANULAR

SILICON DIOXIDE AS A COMPRESSION AID ALONG WITH

BINDERS

DR. MUKESH C. GOHEL 205

151 21-Nov-19 182050820003 Dalwadi Saloniben Bharatbhai MRW304P 20 205 MP Pharmaceutics


FAST


HYBRID LIQUISOLID TECHNIQUE: A NOVEL APPROACH TO

ENHANCE IN VITRO PERFORMANCE OF AN ANTIDIABETIC

DRUG

DR. VAISHALI T. THAKKAR 205

152 21-Nov-19 182050820005 PANCHAL SUMATI ANAMISHARAN MRW304P 20 205 MP Pharmaceutics


FAST


COMPARATIVE EVALUATION OF TWO CONTEMPORARY

METHODS FOR ENHANCING IN-VITRO DISSOLUTION OF

TELMISARTAN EMPLOYING THE CURRENT REGULATORY

REQUIREMENTS


153 21-Nov-19 182050820009 PATHAN LUKMANKHAN SHERKHAN MRW304P 20 205 MP Pharmaceutics


FAST


DEVELOPMENT OF BOSENTAN FORMULATION BY

DISSOLUTION ENHANCEMENT TECHNIQUE USING DESIGN

SPACE.

DR.CHETNA D. MODI 205

154 21-Nov-19 182050820002 CHAUDHARI RUSHIKESH MRW304P 20 205 MP Pharmaceutics MULTIPARTICULATEDESIGN AND DEVELOPMENT OF CLOZAPINE MINITABLET

USING QUALITY BY DESIGN APPROACHMR. HARDIK B. RANA 205

155 21-Nov-19 182050820004 Limarkar Nirmalaben Manubhai MRW304P 20 205 MP Pharmaceutics MULTIPARTICULATE

DEVELOPMENT AND CHARACTERIZATION OF CEFIXIME

GRANULES BY EMPLOYING SYSTEMATIC FORMULATION

APPROACH FOR PEDIATRIC APPLICATION


156 21-Nov-19 182050820007 PATEL DRASHTI SUBHASHCHANDRA MRW304P 20 205 MP Pharmaceutics

NANO



SUPERSTAURATED DRUG DELIVERY SYSTEM: AN

APPROACH TO ENHANCE IN-VITRO DISSOLUTION OF

ATOVAQUONE


157 21-Nov-19 182050820001 BHAVSAR NIRVISHA VIPULCHANDRA MRW304P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG

DELIVERY SYSTEM

DEVELOPMENT OF NEWER VAGINAL FORMULATION OF

HYDROXYPROGESTERONE CAPROATE FOR THE REGULATED

MARKET


158 21-Nov-19 182050820008 PATEL GRISHMA NILESHKUMAR MRW304P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY) PASTILLATIONSYSTEMIC DEVELOPMENT OF PASTILLES CONTAINING

PIPERINE AND ROSUVASTATINMR. HARDIK B. RANA 205

159 21-Nov-19 182050824003 Padavi Sawankumar Rameshbhai MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

SPECTROPHOTOMETRIC AND STABILITY INDICATING HIGH

PERFORMANCE THIN LAYER CHROMATOGRAPHIC

METHOD FOR SIMULTANEOUS ESTIMATION OF

FLUTICASONE PROPIONATE AND MUPIROCIN IN

COMBINED DOSAGE FORM

MR. HITESH G. RAVAL 205

160 21-Nov-19 182050824006 RATHVA PARULBEN JETHABHAI MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING HIGH PERFORMANCE THIN LAYER

CHROMATOGRAPHIC METHOD FOR ESTIMATION OF

FINGOLIMOD HYDROCHLORIDE IN PHARMACEUTICAL

DOSAGE FORM AND ITS DEGRADATION KINETIC STUDY

DR. KALPANA G PATEL 205

161 21-Nov-19 182050824005 PATEL TRUPAL KUMARI RAJESHBHAI MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance


FORMULATION

DEVELOPMENT

AND METHOD

DEVELOPMENT

QBD ASSISTED FORMULATION DEVELOPMENT AND

ANALYTICAL METHOD DEVELOPMENT FOR

SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN AND

DEXAMETHASONE IN NOVEL OPHTHALMIC FORMULATION

DR. PURVI A SHAH 205

162 21-Nov-19 182050824001 CHAVDA NIRALI JAGDIPBHAI MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

SPECTROPHOTOMETRIC AND HIGH PERFORMANCE THIN

LAYER CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS

DETERMINATION OF MOMETASONE FUROATE AND

MUPIROCIN IN COMBINED DOSAGE FORM

MR. HITESH G. RAVAL 205

163 21-Nov-19 182050824002 MANIAR YASH PRADEEPBHAI MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

FORMULATION DEVELOPMENT AND SIMULTANEOUS

ESTIMATION OF FLUTICASONE PROPIONATE AND

OLOPATADINE HYDROCHLORIDE IN NEWLY OPTIMIZED

NASAL FORMULATION BY QBD APPROACH

DR. KALPANA G PATEL 205

164 21-Nov-19 182050824007 Rathwa Nikitaben Vijaykumar MRW304P 24 205 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR SIMULTANEOUS ESTIMATION OF

DOXOFYLLINE AND MONTELUKAST SODIUM IN


DR. PURVI A SHAH 205

165 21-Nov-19 182130828004 PANDYA BHAVIN DIVYESHKUMAR MRW304P 28 213 MPPharmaceutical

Technology


FAST


SOLID DISPERSION ADSORBATE: AN EFFECTIVE METHOD

TO ENHANCE DISSOLUTION AND FLOW PROPERTIES OF

CLOZAPINE

DR ASHOK MAHAJAN 213

166 21-Nov-19 182130820004 KAKASANIA JEEL PINAKINBHAI MRW304P 20 213 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

TOPICAL FOAM FORMULATION OF FLUCONAZOLE FOR

SKIN FUNGAL INFECTIONDR.PRACHI PANDEY 213

167 21-Nov-19 182130828003 MODI JANVIBEN KETANBHAI MRW304P 28 213 MPPharmaceutical

Technology

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF INTRANASAL SPRAY

OF PRAMIPEXOLE DIHYDROCHLORIDEDR. MEENAKSHI PATEL 213

168 21-Nov-19 182130828006 RAIYANI DHARABEN BALUBHAI MRW304P 28 213 MPPharmaceutical

Technology

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

OCULAR NANOSYSTEMS FOR PROLONGED DELIVERY OF

FLURBIPROFEN AND GATIFLOXACINDR. NAAZNEEN SURTI 213

169 21-Nov-19 182130820009 Shah Shrusti Sandip MRW304P 20 213 MP Pharmaceutics

NANO



FORMULATION DEVELOPMENT AND OPTIMIZATION OF

SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM OF

FUROSEMIDE

DR. ADIL PATEL 213

170 21-Nov-19 182130828002 Menon Maanika Kashyap MRW304P 28 213 MPPharmaceutical

TechnologyMISCELANEOUS

MANAGEMENT OF OVERACTIVE BLADDER IN WOMEN :

INTRAVAGINAL RING CONTAINING DARIFENACINDR. MANISHA LALAN 213

171 21-Nov-19 182130820001 CHAVDA DOLLY TRIKAMLAL MRW304P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

PREPARATION AND CHARACTERIZATION OF VAGINAL

DOSAGE FORM OF AN ANTI-HIV DRUGDR. NAAZNEEN SURTI 213

172 21-Nov-19 182130820003 KADAM RUCHITA PANDURANG MRW304P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DISSOLUTION ENHANCEMENT & COLON TARGETED

DELIVERY OF NON-SYSTEMIC ANTIBIOTIC IN THE

MANAGEMENT OF INFLAMMATORY BOWEL DISEASE

DR. MANISHA LALAN 213

173 21-Nov-19 182130820005 MEHTA KHYATI HITESHKUMAR MRW304P 20 213 MP Pharmaceutics


FAST


LIQUISOLID TECHNIQUE FOR DISSOLUTION

ENHANCEMENT OF TYROSINE KINASE INHIBITORDR ASHOK MAHAJAN 213

174 21-Nov-19 182130828005 PATEL DIVYA CHANDRAKANTBHAI MRW304P 28 213 MPPharmaceutical

TechnologyMISCELANEOUS

FORMULATION AND EVALUATION OF NEPAFENAC

MICROEMULSION BASED IN-SITU GEL FOR OCULAR PAIN

MANAGEMENT

DR.PRIYAL PATEL 213

175 21-Nov-19 182130820002 JYOTI JHA MRW304P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)NASAL DRUG

DELIVERY SYSTEM

FORMULATION AND EVALUATION OF MUPIROCIN AND

BECLOMETHASONE INSITU GELLING BIO-ADHESIVE NASAL

FORMULATION FOR MRSA INDUCED RHINOSINUSITIS

DR.PRIYAL R PATEL 213

176 21-Nov-19 182130820006 PATEL JYOTIBEN SANJAYBHAI MRW304P 20 213 MP Pharmaceutics


FAST


SUBLINGUAL DOSAGE FORM OF AN ANTI-EMETIC DRUG DR VANDANA PATEL 213

177 21-Nov-19 182130820007 RAHANGDALE MRUNAL GANESH MRW304P 20 213 MP PharmaceuticsVESICULAR DRUG

DELIVERY SYSTEM

TRANSETHOSOMAL TOPICAL GEL OF APREMILAST FOR

TREATMENT OF PSORIASISDR.PRACHI PANDEY 213

178 21-Nov-19 182130820008 RAMAIYA ZEEL MAHESH MRW304P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF GASTRO RETENTIVE

MULTIPARTICULATE SYSTEM OF LAMOTRIGINEDR. MEENAKSHI PATEL 213

179 21-Nov-19 182130824001 GONDALIA ISHITA ISHWARDAS MRW304P 24 213 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


METHODS FOR ESTIMATION OF REMOGLIFLOZIN

ETABONATE IN TABLET DOSAGE FORM

DR. DIMAL A. SHAH 213

180 21-Nov-19 182130824004 TEWARI AYUSHI RAHUL MRW304P 24 213 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


FOR THE STUDY OF VARDENAFIL HYDROCHLORIDE

TRIHYDRATE

DR. FALGUN A. MEHTA 213

181 21-Nov-19 182130824003 MATUNGI BHUPENDRABHAI PATEL MRW304P 24 213 MP

Pharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY) HYDROTROPY

CONCEPT OF HYDROTROPY IN DEVELOPMENT AND

VALIDATION OF RP-HPLC METHOD FOR DETERMINATION

OF GATIFLOXACIN IN BULK AND EYE DROPS

DR. VANDANA B. PATEL 213

182 21-Nov-19 182230823004 PATEL KIRTAN PINAKIN MRW304P 23 223 MPPharmaceutical

Analysis

SIMULTENEOUS

ESTIMATION


METHODS FOR THE SIMULTANEOUS QUANTIFICATION OF

PERINDOPRIL ERBUMINE, INDAPAMIDE AND AMLODIPINE

BESILATE IN BULK AND PHARMACEUTICAL DOSAGE FORM

DR. USMANGANI K.

CHHALOTIYA223

183 21-Nov-19 182230823001 DEVANSH KANSARA MRW304P 23 223 MPPharmaceutical

Analysis

SIMULTENEOUS

ESTIMATION


METHODS FIMASARTAN POTASSIUM TRIHYDRATE,

ROSUVASTATIN CALCIUM AND AMLODIPINE BESYLATE IN

BULK AND SYNTHETIC MIXTURE

DR. USMANGANI K.

CHHALOTIYA223

184 21-Nov-19 182230823003 PATEL JAYKUMAR KAUSHIKBHAI MRW304P 23 223 MPPharmaceutical

Analysis

SIMULTENEOUS

ESTIMATION


METHODS FOR THE SIMULTANEOUS ESTIMATION OF

MINOXIDIL AND FINASTERIDE IN BULK AND MARKETED

FORMULATION

MRS. JINAL TANDEL 223

185 21-Nov-19 182230823002 PATEL ISHITA MANISHBHAI MRW304P 23 223 MPPharmaceutical

Analysis

SIMULTENEOUS

ESTIMATION

ANALYTICAL METHODS DEVELOPMENT AND VALIDATION

FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN,

LINAGLIPTIN AND METFORMIN IN SYNTHETIC MIXTURE

MRS HARSHA D JANI 223

186 21-Nov-19 182240824002 Modi Palak Ghanshyambhai MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING HPLC METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS ESTIMATION OF

AMLODIPINE AND CELECOXIB IN PHARMACEUTICAL

DOSAFE FORMS

DR. HIRAL PANCHAL 224

187 21-Nov-19 182240824005 Shah Ami Kaushikbhai MRW304P 24 224 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING HPLC METHOD FOR ESTIMATION OF

RASAGLINE MESYLATE IN TABLETS

MRS. MITALI JASANI 224

188 21-Nov-19 182240824001 HEENABEN MUKUNDBHAI PATEL MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance


METHOD

DEVELOPMENT

AND VALIDATION

BY HPLC

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR

ESTIMATION OF REMOGLIFILOZIN IN TABLET DOSAGE

FORM


189 21-Nov-19 182240824003 Nimavat Tanveeben Govindbhai MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance


METHOD

DEVELOPMENT

AND VALIDATION

BY HPLC


FOR ESTIMATION OF ALPELISIB BY HPLC IN

PHARMACEUTICAL DOSAGE FORMS


190 21-Nov-19 182240824004 RAVAL JEET MANOJKUMAR MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance


METHOD

DEVELOPMENT

AND VALIDATION

BY HPLC

HPLC METHOD DEVELOPMENT AND VALIDATION FOR

ESTIMATION OF PEXIDARTINIB IN PHARMACEUTICAL

DOSAGE FORMS

MRS. MITALI JASANI 224

191 21-Nov-19 182240824006 Sheetal Rajendrakumar Sheth MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance


METHOD

DEVELOPMENT

AND VALIDATION

BY HPLC


FOR ESTIMATION OF FEDRATINIB IN PHARMACEUTICAL

DOSAGE FORM BY HPLC

MS. DIVYA THAKKAR 224

192 21-Nov-19 182240824007 Tiwari Annu Rajeshkumar MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



TEICOPLANIN AND ITS IMPURITIES IN PHARMACEUTICAL

DOSAGE FORM


193 21-Nov-19 182240824008 Tiwari Ashima Arunkumar MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



VILDAGLIPTIN AND ITS IMPURITIES IN PHARMACEUTICAL

DOSAGE FORM

MS. DIVYA THAKKAR 224

194 21-Nov-19 182240824009 Upadhyay Kalpeshkumar Jagdishchandra MRW304P 24 224 MP

Pharmaceutical

Quality

Assurance


METHOD

DEVELOPMENT

AND VALIDATION

BY HPLC


FOR ESTIMATION OF TIOPRONIN IN BULK AND

PHARMACEUTICAL DOSAGE FORMS BY HPLC


195 21-Nov-19 182350820001 JADHAV DIVYA HEMANTBHAI MRW304P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN DEVELOPMENT AND OPTIMIZATION OF

MUCOADHESIVE IN-SITU NASAL GEL CONTAINING

XYLOMETAZOLINE HYDROCHLORIDE

DR HITESH JAIN 235

196 21-Nov-19 182350820002 SHARMA KUSUM NARESH MRW304P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF

PAROXETINE HYDROCHLORIDE LOADED TRANSDERMAL

PATCH

DR ASIT R SAHU 235

197 21-Nov-19 182350820004 SHUKLA RUCHI RAJDHAR MRW304P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN DEVELOPMENT AND OPTIMIZATION OF TOPICAL

BIGEL CONTAINING MOMETASONE FUROATEDR HITESH JAIN 235

198 21-Nov-19 182350820005 SRIVASTAVA ANKITA ASHOK MRW304P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF FUSIDIC ACID

EMULGELDR. SHARAV DESAI 235

199 21-Nov-19 182350820003 SHETH MAITRY SANKETKUMAR MRW304P 20 235 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND CHARACTERIZATION OF SUSTAINED

RELEASE FLOATING MICROBALLOONS CONTAINING

ALLOPURINOL

DR HITESH JAIN 235

200 21-Nov-19 182350820008 VEEDHI RAJENDRAKUMAR RATHAWA MRW304P 20 235 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF IN-SITU

OPHTHALMIC GEL CONTAINING ECONAZOLE NITRATEDR SHARAV DESAI 235

201 21-Nov-19 182350820007 Trivedi Monika Vijaybhai MRW304P 20 235 MP Pharmaceutics


FAST


FORMULATION, DEVELOPMENT AND AND EVALUATION OF

IMMEDIATE RELEASE FIXED DOSE COMBINATION OF ANTI-

HYPERTENSIVE AGENTS

DR ASIT R SAHU 235

202 21-Nov-19 182350820006 SURVE ROOSHALI SANJAY MRW304P 20 235 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF MICROSPONGE

BASED COLON SPECIFIC TABLET OF MEBENDAZOLEDR SHARAV DESAI 235

203 21-Nov-19 182350820009 VRUNDABEN PATEL MRW304P 20 235 MP Pharmaceutics MULTIPARTICULATE

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF

EXTENDED RELEASE PELLETS CONTAINING ANTI-EPILEPTIC

DRUG

DR ASIT R SAHU 235

204 21-Nov-19 182350824001 ADESHRA SHREYA DINESHBHAI MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF EFONIDIPINE

HYDROCHLORIDE ETHANOLATE AND TELMISARTAN IN

THEIR SYNTHETIC MIXTURE

MS. GRISHMA PATEL 235

205 21-Nov-19 182350824002 Bandwala faiz shabbirHusain MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR ESTIMATION OF DRUGS IN THEIR COMBINED DOSAGE

FORM

MS. GRISHMA PATEL 235

206 21-Nov-19 182350824003 CHUDASAMA VIRANGI HITESHBHAI MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF MUPIROCIN AND

METHYLPREDNISOLONE IN THEIR COMBINED DOSAGE

FORM

MR. TEJAS PATEL 235

207 21-Nov-19 182350824011 SHAH KESHA KIRANKUMAR MRW304P 24 235 MPPharmaceutical

Quality

Assurance

PROCESS VALIDATIONPROCESS VALIDATION OF METRONIDAZOLE FILM COATED

TABLET DR. PRASANNA PRADHAN 235

208 21-Nov-19 182350824004 daraji hitanshi pareshkumar MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF EFONIDIPINE

HYDROCHLORIDE ETHANOLATE AND METOPROLOL

SUCCINATE IN THEIR SYNTHETIC MIXTURE

DR. PRASANNA PRADHAN 235

209 21-Nov-19 182350824005 KANSOTIA RUCHI MANGILAL MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF LULICONAZOLE AND

TERBINAFINE HCL IN PHARMACEUTICAL DOSAGE FORM

DR. DHARA PATEL 235

210 21-Nov-19 182350824006 PARMAR RIPPLE NARENDRABHAI MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF ACECLOFENAC,

TOLPERISONE AND PARACETAMOL IN TABLET

FORMULATION

DR. PRASANNA KUMAR

PRADHAN235

211 21-Nov-19 182350824007 PATEL HIRALBEN KAUSHIKBHAI MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF ALCAFTADINE AND

KETOROLAC TROMETHAMINE IN SYNTHETIC MIXTURE.

DR. DHARA PATEL 235

212 21-Nov-19 182350824008 Patel Kajalben Jayeshkumar MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND

TELMISARTAN IN THEIR SYNTHETIC MIXTURE

DR. PRASANNA KUMAR

PRADHAN235

213 21-Nov-19 182350824009 Patel khyati jayendrabhai MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHOD FOR SIMULTANEOUS ESTIMATION OF

ATORVASTATIN CALCIUM AND VITAMIN D3

(CHOLECALCIFEROL) IN THEIR COMBINED DOSAGE FORM

DR. DHANANJAY

MESHRAM235

214 21-Nov-19 182350824010 Radharapu Satchitkrishna Chandrashekhar MRW304P 24 235 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF PAROXETINE HCL

AND ETIZOLAM IN PHARMACEUTICAL DOSAGE FORM

DR. DHARA PATEL 235

215 21-Nov-19 182440820001 Gandhi Rukma Shishirkumar MRW304P 20 244 MP Pharmaceutics


FAST



ORAL FILM OF ANTIPSHYCHOTIC AGENT PALIPERIDONE.M. RAHIL BHURA 244

216 21-Nov-19 182440820002 Jayswal Durgeshkumar Dipakkumar MRW304P 20 244 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF SUBLINGUAL TABLET

OF BUSPIRONE HYDROCHLORIDE M. RAHIL BHURA 244

217 21-Nov-19 182440820003 Solanki Nikulkumar Raghabhai MRW304P 20 244 MP Pharmaceutics


FAST



FILM OF IVABRADINE HCLMEHUL VYAS 244

218 21-Nov-19 182450820001 ARYA UDAYKUMAR KISHANLAL MRW304P 20 245 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


TABLET OF CLOMIPRAMINEDR. P. H. PRAJAPATI 245

219 21-Nov-19 182450824003 PATEL KRUPABEN NARESHKUMAR MRW304P 24 245 MPPharmaceutical

Quality

Assurance


QUANTITATIVE

METHOD

DEVELOPMENT

QUANTITATIVE ANALYTICAL METHOD DEVELOPMENT AND

VALIDATION FOR TERIFLUNOMIDE IN PHARMACEUTICAL

DOSAGE FORM

DR. LAXMAN M PRAJAPATI 245

220 21-Nov-19 182450824001 Akhani Vaibhavi Nitinkumar MRW304P 24 245 MPPharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY) METHOD

DEVELOPMENT


FOR ESTIMATION OF PRUCALOPRIDE SUCCINATE IN


DR. LAXMAN M PRAJAPATI 245

221 21-Nov-19 182450824004 SANYAL ASTHA PRAVINBHAI MRW304P 24 245 MP

Pharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY) QBD APPROACH


FOR SAROGLITAZAR IN PHARMACEUTICAL DOSAGE FORM

BY QBD APPROACH

DR. CHHAGANBHAI N

PATEL245

222 21-Nov-19 182450824005 Shah Hemant Yogeshbhai MRW304P 24 245 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


DEVELOPMENT AND VALIDATION FOR ESTIMATION OF

ZONISAMIDE IN PHARMACEUTICAL DOSAGE FORM

MR. PRUTHVIRAJ K

CHAUDHARY245

223 21-Nov-19 182450824002 PATEL ARATIBEN MANUBHAI MRW304P 24 245 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES



BILASTINE IN PHARMACEUTICAL DOSAGE FORM

DR. CHHAGANBHAI N

PATEL245

224 22-Nov-19 182280826001 FEFAR NIDHIBEN RAMESHBHAI MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: PREPARATION AND SCREENING OF BOTANICAL

FORMULATIONS WITH ANTI- ACNE POTENTIAL. PART B:

ISOLATION OF MAJOR COUMARIN/S FROM

PLEUROSPERMUM ANGELICOIDES.

DR. MAMTA B SHAH 228

225 22-Nov-19 182280826002 JHALA SHAILJA BALBHADRASINH MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: ISOLATION OF BIOACTIVES FROM CRATAEVA

NURVALA. PART B: DEVELOPMENT AND EVALAUTION OF

MOSQUITO REPELLENT HERBAL FORMULATION.


226 22-Nov-19 182280826003 Soni Bhoomi Paraskumar MRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: DEVELOPMENT AND ANALYSIS OF HERBAL ANTI

AGING SKIN CARE PRODUCTS PART B: ISOLATION OF

MAJOR BIOACTIVE FROM GARCINIA INDICA.


227 22-Nov-19 182280826004TATMA SHAMBHUKUMAR

SHRIBALKRISHNADASMRW304P 26 228 MP Pharmacognosy HERBAL RESEARCH

PART A: DEVELOPMENT OF HERBAL SUPPLEMENT FOR

DIABETES MITIGATION. PART B: METHOD DEVELOPMENT

FOR ISOLATION OF PHENOLIC CONSTITUENT/S OF

PSORALEA CORYLIFOLIA.


228 22-Nov-19 182390820009 PATEL HEMAXIBEN HITENDRA MRW304P 20 239 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DEVELOPMENT, EVALUATION AND OPTIMIZATION OF

DACARBAZINE LOADED SOLID LIPID NANOPARTICLE BASED

TOPICAL GEL

DR. KOMAL PARMAR 239

229 22-Nov-19 182390820004 HALPATI KARTIK THAKORBHAI MRW304P 20 239 MP Pharmaceutics


FAST


FORMULATION AND CHARACTERIZATION OF SPHERICAL

AGGLOMERATES FOR SOLUBILITY ENHANCEMENT OF THE

ABIRATERONE ACETATE USING QBD APPROACH

DR. HITESH DALVADI 239

230 22-Nov-19 182390820005 Joshi Chaitanya harshadkumar MRW304P 20 239 MP Pharmaceutics


FAST


DEVELOPMENT AND OPTIMIZATION OF ORALLY

DISINTEGRATING FILMMR. TULARAM BAROT 239

231 22-Nov-19 182390820006 MAURAYA RAJESHKUMAR KRUPASANKAR MRW304P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT AND CHARACTERIZATION OF INTRANASAL

IN SITU GEL OF NANOPARTICULATED POLYMERIC

CARRIERS CONTAINING TEMOZOLOMIDE


232 22-Nov-19 182390820008 PATEL DEVYANGI PRAKASH MRW304P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT AND EVALUATION OF IN-SITU GEL FOR THE

TREATMENT OF GASTRIC ULCERMR. TULARAM BAROT 239

233 22-Nov-19 182390820011 SOLANKI HARDIK MAHENDRASINH MRW304P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN AND CHARACTERIZATION OF IRINOTECAN

HYDROCHLORIDE LOADED COLON TARGETED BEADS

USING QBD APPROACH


234 22-Nov-19 182390820012 YADAV SUNITA ACHCHHELAL MRW304P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND CHARACTERIZATION OF INJECTABLE

IN-SITU IMPLANT DRUG DELIVERY FOR ANTICANCER DRUG

OF ABIRATERONE ACETATE


235 22-Nov-19 182390820002 DHONDE BHOOMI YOGESHKUMAR MRW304P 20 239 MP Pharmaceutics

NANO



DEVELOPMENT AND CHARACTERIZATION OF EXEMESTANE

LOADED LIPID-POLYMER HYBRID NANOPARTICLESDR. KOMAL PARMAR 239

236 22-Nov-19 182390820003 HALPATI DIPESHBHAI GANPATBHAI MRW304P 20 239 MP Pharmaceutics MISCELANEOUSDEVELOPMENT AND OPTIMIZATION OF SPHERICAL

AGGLOMERATES OF CLOZAPINEMR. TULARAM BAROT 239

237 22-Nov-19 182390820007 MAV URVI GOPALBHAI MRW304P 20 239 MP Pharmaceutics

NANO



DEVELOPMENT, EVALUATION AND OPTIMIZATION OF LIPID

POLYMER HYBRID NANOPARTICLE BASED INHALER

CONTAINING PYRAZINAMIDE


238 22-Nov-19 182390820010 PATEL YASH VIJAYKUMAR MRW304P 20 239 MP Pharmaceutics MULTIPARTICULATEDEVELOPMENT AND CHARACTERIZATION OF GEMCITABINE

NANOPARTICLESDR. KOMAL PARMAR 239

239 22-Nov-19 182390824001 ANCHAL SINGH MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

SIMULTANEOUS ESTIMATION OF FUSIDIC ACID AND

BECLOMETHASONE DIPROPIONATE BY

CHROMATOGRAPHIC METHOD IN THEIR


MRS.MADHURI HINGE 239

240 22-Nov-19 182390824002 Bhandari Truptiben Ramjibhai MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR SIMULTANEOUS ESTIMATION OF TIMOLOL

MALEATE AND PILOCARPINE NITRATE IN COMBINED

DOSAGE FORM

DR. ALISHA PATEL 239

241 22-Nov-19 182390824003 DESAI ANAL PARIMAL MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

ANALYTICAL METHOD DEVELOPMENT AND ITS

VALIDATION FOR ESTIMATION OF NADIFLOXACIN AND

ADAPALENE IN THEIR COMBINED TOPICAL FORMULATION.

MRS. SHUCHI DESAI 239

242 22-Nov-19 182390824004 DESAI SALONI SANJAYBHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

METHODS DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF HYDROCORTISONE

ACETATE AND ATROPINE SULPHATE IN MARKETED

FORMULATION


243 22-Nov-19 182390824005 Dhodi Khyati Khalpa MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



LEVOFLOXACIN AND PREDNISOLONE ACETATE IN

SYNTHETIC MIXTURE


244 22-Nov-19 182390824006 NAIK SHREYA NARESHBHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF NADIFLOXACIN AND

MOMETASONE FUROATE IN SEMISOLID DOSAGE FORM.

MRS. SHUCHI DESAI 239

245 22-Nov-19 182390824007 PARMAR DRASTI MUKESHSINH MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE IN


MRS. MADHURI HINGE 239

246 22-Nov-19 182390824008 PATEL KHUSHBU BHARATBHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR CLOBETASOL PROPIONATE AND

CLOTRIMAZOLE IN THEIR COMBINED PHARMACEUTICAL

DOSAGE FORM.

MRS. MEGHA SHAH 239

247 22-Nov-19 182390824009 PATEL PRACHIBEN JITENDRABHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

SIMULTANEOUS ESTIMATION OF METFORMIN

HYDROCHLORIDE AND ALPHA LIPOIC ACID BY

CHROMATOGRAPHIC METHOD IN PHARMACEUTICAL

DOSAGE FORM


248 22-Nov-19 182390824010 PATEL PREETI DILIP MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



ARIPIPRAZOLE AND ESCITALOPRAM OXALATE IN

SYNTHETIC MIXTURE


249 22-Nov-19 182390824011 PATEL PRIYABEN BIPINBHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



HYDROCORTISONE ACETATE AND CHLORAMPHENICOL IN

THEIR COMBINED DOSAGE FORM

MS. RAJVI MAHIDA 239

250 22-Nov-19 182390824012 PATEL RUPALI RAVINDRABHAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE

AND ZINC PYRITHIONE IN THEIR COMBINED MARKETED

FORMULATION.

MRS. MEGHA SHAH 239

251 22-Nov-19 182390824013 Patel Trigal Jayeshbhai MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



CLOBETASOL PROPIONATE AND MICONAZOLE NITRATE IN

THEIR COMBINED DOSAGE FORM


252 22-Nov-19 182390824014 PRAJAPATI RITA BHAGVANDAS MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



HYDROCORTISONE ACETATE, BENZOIC ACID AND SALICYLIC

ACID IN THEIR PHARMACEUTICAL DOSAGE FORM

MS.RAJVI MAHIDA 239

253 22-Nov-19 182390824015 ZALAK DESAI MRW304P 24 239 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

ANALYTICAL METHODS DEVELOPMENT AND VALIDATION

FOR SIMULTANEOUS ESTIMATION OF SODIUM BENZOATE

AND SODIUM PHENYLACETATE IN SYNTHETIC MIXTURE

DR.ALISHA PATEL 239

254 22-Nov-19 182540820001 BHARODIYA KISHAN VITTHALBHAI MRW304P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF SERTACONAZOLE

NITRATE EMULGEL FOR TOPICAL DRUG DELIVERYDR. MANISH GOYANI 254

255 22-Nov-19 182540820003 KOLYA MEHRUNNISHA MAHAMAD MRW304P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF TOPICAL SPRAY FOR

THE TREATMENT OF FUNGAL INFECTIONDR. MANISH GOYANI 254

256 22-Nov-19 182540820006 PATEL PINKISABEN SUBHASHBHAI MRW304P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF BIFONAZOLE

ETHOSOMAL GEL FOR TOPICAL DRUG DELIVERYDR. MANISH GOYANI 254

257 22-Nov-19 182540820008 SINGH SHIKHAKUMARI VINOD MRW304P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF CYCLOSPORINE

TRANSFEROSOMAL GEL FOR TOPICAL DRUG DELIVERYDR. MANISH GOYANI 254

258 22-Nov-19 182540820007 RATHWA SURDAS KHUMANBHAI MRW304P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

PREPARATION AND EVALUATION OF CITRIC ACID CROSS

LINKED GELLAN GUM BASED HYDROGEL FOR DRUG

DELIVERY

DR. ANAND DESHMUKH 254

259 22-Nov-19 182540820004 PANDYA PRIYANKA HARSHADBHAI MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

DEVELOPMENT AND COMPARATIVE EVALUATION OF

ORGANICALLY MODIFIED NANO-COMPOSITE CLAY BASED

GELS FOR TREATMENT OF ARTHRITIS

MR. SUSHIL RAUT 254

260 22-Nov-19 182540820005 PATEL JINALKUMARI RAJESHBHAI MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

FORMULATION AND CHARACTERIZATION OF NANO-

COMPOSITE CLAY-DRUG COMPLEXES FOR ORAL DELIVERY

OF IBUPROFEN

MR. SUSHIL RAUT 254

261 22-Nov-19 182540820009 TIWARI PRATIBHA AJAY MRW304P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)NANO COMPOSITE

SYSTEMS

DEVELOPMENT AND COMPARISON OF POLYMERIC GELS

CONTAINING NANO-COMPOSITE CLAY-DRUG HYBRID

SYSTEM FOR WOUND HEALING

MR. SUSHIL RAUT 254

262 22-Nov-19 182540820002 JADAV VISHALSING RAJESING MRW304P 20 254 MP Pharmaceutics

NANO



FORMULATION AND EVALUATION OF NANOEMULSION

FOR ORAL BIOAVAILABILITY ENHANCEMENT OF

LORATADINE

MR. SUSHIL RAUT 254

263 22-Nov-19 182570820001 BHOJ HETAL DINESHBHAI MRW304P 20 257 MP Pharmaceutics

NANO



DESIGN AND DEVELOPMENT OF ZOLMITRIPTAN LOADED

NANOSTRACTURED LIPID CARRIERS (NLC) FOR TREATMENT

OF MIGRAINE

DR. ARA T. PATEL 257

264 22-Nov-19 182570824002 KHATRI VANITA AMARSINGH MRW304P 24 257 MPPharmaceutical

Quality

Assurance

BIOANALYTICAL

DEVELOPMENT AND VALIDATION OF BIOANALYTICAL

METHOD FOR ESTIMATION OF ORCIPRENALINE SULPHATE

IN RAT PLASMA BY LC-MS/MS

OJAS PATEL 257

265 22-Nov-19 182570824003 MANOJKUMAR MRW304P 24 257 MPPharmaceutical

Quality

Assurance

PROCESS VALIDATIONANNUAL PRODUCT QUALITY REVIEW (APQR) OF

TOPIRAMATE TABLETS USP 200 MGDR. HARSHA U. PATEL 257

266 22-Nov-19 182570824001 HARMANI NIRAV JAYSUKHBHAI MRW304P 24 257 MP

Pharmaceutical

Quality

Assurance


DEVELOPMENT


FOR THE ESTIMATION OF DAROLUTAMIDE BY HPLC IN

BULK AND PHARMACEUTICAL DOSAGE FORM

DR. HARSHA U. PATEL 257

267 22-Nov-19 182570824004 PANCHAL PUJA RAMESHBHAI MRW304P 24 257 MP

Pharmaceutical

Quality

Assurance


DEVELOPMENT


FOR THE ESTIMATION OF PEXIDARTINIB BY HPLC IN BULK

AND PHARMACEUTICAL DOSAGE FORM

NEHA S. MOCHI 257

268 22-Nov-19 182600826001 VACHHANI TWINKLE MAHESHBHAI MRW304P 26 260 MP Pharmacognosy HERBAL RESEARCHPREPARATION AND EVALUATION OF POLY-HERBAL

FORMULATION FOR ARTHRITISMRS. PAYAL SUTHAR 260

269 22-Nov-19 182650820002 MODI KSHEMUBEN SATISHKUMAR MRW304P 20 265 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION,DEVELOPMENT AND EVALUATION OF

MICROEMULGEL OF EBERCONAZOLE FOR TOPICAL DRUG

DELIVERY

DR. ANURADHA P.

PRAJAPATI265

270 22-Nov-19 182650820001 Bhamtikar Krutik Kanti MRW304P 20 265 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN AND CHARACTERIZATION OF TRANSDERMAL

PATCH OF CLOXACILLINE SODIUMDR.KANTILAL B. NARKHEDE 265

271 22-Nov-19 182650820004 PATEL HARSHALKUMAR MAGANBHAI MRW304P 20 265 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION,DEVELOPMENT AND EVALUATION OF

NASAL SPAY CONTAINING ANTI HISTAMINIC DRUG

DR. ANURADHA P.

PRAJAPATI265

272 22-Nov-19 182650820003 NADA CHIRAG DHIRUBHAI MRW304P 20 265 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

FORMULATION AND EVALUATION OF NANOPARTICLE

LOADED DRUG DELIVERY FOR IMPROVING IN VITRO DRUG

RELEASE OF ANTIMALARIAL DRUG

MR.AJAY N.TALELE 265

273 22-Nov-19 182650820005 PATEL SAVANKUMAR PRAVINBHAI MRW304P 20 265 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

FORMULATION ,DEVELOPMENT AND EVALUATION ANTI

ASTHMATIC DRUG IN LOZENGES

DR. KANTILAL B.

NARKHEDE265

274 22-Nov-19 182650820006 SINHA SWATE ABHAY MRW304P 20 265 MP Pharmaceutics


FAST


FORMULATION,DEVELOPMENT AND EVALUATION OF AN

IMMEDIATE RELEASE ANTIGOUT DRUG FOR TREATMENT

OF ACUTE GOUT

MR. AJAY N. TALELE 265

275 22-Nov-19 182650824001 AHIR HETVIBEN MANGUBHAI MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE

FORM

DR. D. P. DAMAHE 265

276 22-Nov-19 182650824007 PATEL HEMANGI ARVINDBHAI MRW304P 24 265 MPPharmaceutical

Quality

Assurance

BIOANALYTICAL

BIOANALYTICAL METHOD DEVELOPMENT AND

VALIDATION FOR ESTIMATION OF AZILSARTAN IN K3EDTA

HUMAN PLASMA BY USING LC-ESI-MS-MS

DR. SACHIN B. NARKHEDE 265

277 22-Nov-19 182650824006 PATEL DRASTI ANUPBHAI MRW304P 24 265 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM,

AMLODIPINE BESYLATE AND CHLORTHALIDONE BY RP-

HPLC METHOD

DR. SHAILESH V LUHAR 265

278 22-Nov-19 182650824005 PAREKH KALGI DIVYESH MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


AMBROXOL HYDROCHLORIDE, CHLORPHENIRAMINE

MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE IN

COMBINED DOSAGE FORM


279 22-Nov-19 182650824004 GORI HAYA AMBALAL MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

METHOD DEVELOPMENT AND VALIDATION OF

DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE

AND CHLORPHENIRAMINE MALEATE IN COMBINED

DOSAGE FORM BY HPTLC


280 22-Nov-19 182650824003 DHIMMAR MAITRI NAVINCHANDRA MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METRONIDAZOLE, FURAZOLIDONE AND DICYCLOMINE

HYDROCHLORIDE IN TABLET DOSAGE FORM BY HPTLC

DR. SACHIN B. NARKHEDE 265

281 22-Nov-19 182650824008 PATEL KRINA SURYAKANT MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


TELMISARTAN AND BENIDIPINE HYDROCHLORIDE IN

PHARMACEUTICAL DOSAGE FORM BY HPTLC

DR. D. P. DAMAHE 265

282 22-Nov-19 182650824002 BAGDA NISHA DINESH MRW304P 24 265 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR ESTIMATION OF CILNIDIPINE AND BISOPROLOL

FUMARATE IN PHARMACEUTICAL DOSAGE FORM BY HPTLC

.

DR.D.P.DAMAHE 265

283 22-Nov-19 182670824001 VISHAL KUMAR PATHAK MRW304P 24 267 MP

Pharmaceutical

Quality

Assurance


QBD APPROACH,

ANALYTICAL

METHOD

DEVELOPMENT

AND VALIDATION

APPLICATION OF NOVEL QBD APPROACH IN ANALYTICAL

METHOD DEVELOPMENT AND VALIDATION FOR THE

QUANTITATIVE ANALYSIS OF CO-ENZYME Q10 IN SINGLE

AND COMBINED DOSAGE FORMS

DR. BHARATKUMAR

GANESHBHAI CHAUDHARI267

284 22-Nov-19 182680820002 CHAUDHARY PRIYAVANDA BIPINBHAI MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

PREPARATION, OPTIMIZATION AND EVALUATION OF

ACYCLOVIR LOADED MICROEMULSION GEL FOR TOPICAL

DELIVERY

DR. DIXIT C MODI 268

285 22-Nov-19 182680820003 MISTRY STUTIBEN NARESHKUMAR MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF NANOCARRIERS

LOADED WITH CALCITONIN FOR ANTIRESORPTIVE

TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS

INTRANASALLY

MRS. SONAL N SOLANKI 268

286 22-Nov-19 182680820001 Basavaraj Savanoor MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

EXPLORATION OF CLEARGEL TECHNOLOGY FOR ENHANCED

TOPICAL DELIVERY OF POORLY SOLUBLE DRUG.DR. DHIREN P SHAH 268

287 22-Nov-19 182680820004 PATEL DHRUVKUMAR NILESHBHAI MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN,DEVELOPMENT AND CHARACTERIZATION OF

NANOPARTICLE LOADED TOPICAL GEL OF APREMILAST.MR. TEJAS J PATEL 268

288 22-Nov-19 182680820006 PATEL MOHINIBEN SHAILESHBHAI MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF MUCOADHESIVE

VAGINAL FILM OF OXYBUTYNIN

DR. JITENDRA SINGH

YADAV268

289 22-Nov-19 182680820011 THAKOR HELI NILAYKUMAR MRW304P 20 268 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

NANOEMULSION BASED HYDROGEL OF LULICONAZOLE :

AN INNOVATIVE APPROACH FOR TOPICAL DRUG DELIVERY DR. RUMIT M SHAH 268

290 22-Nov-19 182680820009 SINGH NEHA GOPAL MRW304P 20 268 MP Pharmaceutics MISCELANEOUSCAN PHARMACEUTICAL WAXES BE SOLUBILIZER FOR

DRUGS. “ A FEASIBILITY STUDY”

DR. JITENDRA SINGH

YADAV268

291 22-Nov-19 182680820005 PATEL HARSH DILIPKUMAR MRW304P 20 268 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN, DEVELOPMENT AND EVALUATION OF MULTIPLE-

UNIT FLOATING – BIOADHESIVE MINITABLETS

DR. JITENDRA SINGH

YADAV268

292 22-Nov-19 182680820007 PATEL SARANGKUMAR MANOJBHAI MRW304P 20 268 MP Pharmaceutics


FAST


DESIGN, DEVELOPMENT AND CHARACTERIZATION OF

PROMETHAZINE HCL ORODISPERSIBLE TABLETDR. DHIREN P SHAH 268

293 22-Nov-19 182680820008 PATEL SEJALKUMARI BABUBHAI MRW304P 20 268 MP Pharmaceutics


FAST


DESIGN,DEVELOPMENT AND CHARACTERIZATION OF FAST

DISSOLVING ORAL FILM OF HALOPERIDOL.MR. TEJAS J PATEL 268

294 22-Nov-19 182740824001 KARDANI MONALIBEN DILIPBHAI MRW304P 24 274 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR NEPAFENAC AND DEXAMETHASONE IN

COMBINATION

DR. H A RAJ 274

295 22-Nov-19 182740824002 KUSHWAHA RAMPYARI RAMGOPAL MRW304P 24 274 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR PARACETAMOL, IBUPROFEN AND

DEXAMETHASONE IN COMBINATION

DR. H A RAJ 274

296 22-Nov-19 182740824004 Rawal Sneha Kishorkumar MRW304P 24 274 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


METHODS FOR MOXIFLOXACIN AND CLOTRIMAZOLE IN

COMBINATION

DR. H A RAJ 274

297 25-Nov-19 182020822002 Patel Khushboo Hiteshbhai MRW304P 22 202 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY)

MEDICINAL

CHEMISTRY (ANTI

OBESITY AGENTS)

DESIGN, SYNTHESIS AND PANCREATIC LIPASE INHIBITORY

ACTIVITY OF NOVEL QUINAZOLINE DERIVATIVES AS ANTI-

OBESITY AGENTS

DR. VIPUL M. VAGHELA 202

298 25-Nov-19 182020822001 KAPUPARA CHARVI ASHOKBHAI MRW304P 22 202 MPPharmaceutical


MEDICINAL

CHEMISTRY (ANTI

TUBERCULAR

AGENTS)

SYNTHESIS AND SCREENING OF BENZIMIDAZOLE

DERIVATIVES AS ANTI TUBERCULAR AGENTSDR. DINESH V. THAKKAR 202

299 25-Nov-19 182050828002 Nisha Choudhary MRW304P 28 205 MPPharmaceutical

Technology

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

SYSTEMATIC SCRUTINISATION OF VITAL FACTORS FOR

DEVELOPING FORMULATION OF MODEL POORLY SOLUBLE

DRUG VIA MOISTURE ACTIVATED DRY GRANULATION

TECHNOLOGY: AN EFFORT TO DEMONSTRATE THE USE OF

LEAN DRUG MANUFACTURING

MS. DIPIKA CHAVDA 205

300 25-Nov-19 182050828001 Asmita MRW304P 28 205 MPPharmaceutical

TechnologyMULTIPARTICULATE

DEVELOPMENT OF SUPERDISINTEGRATING IMMEDIATE

RELEASE FEBUXOSTAT PELLETS BY INCORPORATING NOVEL

EXCIPIENTS


301 25-Nov-19 182050828003 SANDEEP SATISHBHAI AGRAWAL MRW304P 28 205 MPPharmaceutical

TechnologyOTHER (KINDLY SPECIFY)

NOVEL

COMPRESSION

TECHNOLOGY

NOVEL TECHNIQUE FOR PREPARING METFORMIN BILAYER

TABLET DR. MUKESH C. GOHEL 205

302 25-Nov-19 182120820001 AHIR TEJASKUMAR ASHOKBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY) COCRYSTALS

STUDIES IN FORMULATION AND EVALUATION OF

TADALAFIL COCRYSTAL TO IMPROVE DISSOLUTION

CHARACTERISTICS

DR. JAYANT R. CHAVDA 212

303 25-Nov-19 182120820003 CHAUHAN HARDIK ALPESHBHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

FORMULATION AND EVALUATION OF AMOXICILLIN

TRIHYDRATE SOLID DISPERSION BY SPRAY DRYING

DR.CHETAN H.

BORKHATARIA212

304 25-Nov-19 182120820006 KALASARIYA SANJAYKUMAR NATHABHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

ENHANCEMENT OF SOLUBILITY AND IMPROVEMENT OF

PHYSICOCHEMICAL PROPERTIES BY FORMULATING SPRAY

DRIED SOLID DISPRSION OF DARUNAVIR ETHANOLATE

DR.M. M. SONIWALA 212

305 25-Nov-19 182120820007 MIR DEVALBEN BHANABHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF

ETORICOXIB BY SPHERICAL AGGLOMERATIONDR.M. M. SONIWALA 212

306 25-Nov-19 182120820002 BHALODIA KULDEEP KANTILAL MRW304P 20 212 MP Pharmaceutics

NANO



FORMULATION AND EVALUATION OF SOLID SELF MICRO

EMULSIFYING DRUG DELIVERY SYSTEM OF DASATINIBMR. KALPESH A. PATEL 212

307 25-Nov-19 182120820009 PATEL HEMAKSHIBEN DHIRAJLAL MRW304P 20 212 MP Pharmaceutics MULTIPARTICULATE

DESIGN, DEVELOPMENT AND OPTIMIZATION OF

PALIPERIDONE LOADED CHITOSAN NANOPARTICLES FOR

INTRANASAL DELIVERY

DR. SUNNY R. SHAH 212

308 25-Nov-19 182120820010 PATEL PARTHKUMAR HASMUKHBHAI MRW304P 20 212 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF DOSAGE FORM

CONTAINING PELLETS FOR ANTIPSYCHOTIC THERAPYDR.JAYDEEP.M.PATEL 212

309 25-Nov-19 182120820004 GANGANI USHABEN RAMESHBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY)SOLUBILITY

ENHANCEMENT

STUDY OF INVITRO MODULATORY EFFECT OF PH ON

HYDROXYPROPYL BETA CYCLODEXTRIN COMPLEX OF

POORLY SOLUBLE DRUG

DR. JAYANT R. CHAVDA 212

310 25-Nov-19 182120820005 GOSAI SHIVANGPARI MAHESHPARI MRW304P 20 212 MP Pharmaceutics

NANO




CARVEDILOL DRY EMULSION USING SPRAY DRYING

TECHNIQUE

DR. DIPEN R. BHIMANI 212

311 25-Nov-19 182120820011 RANPARIYA FENIL MANSUKHBHAI MRW304P 20 212 MP Pharmaceutics OTHER (KINDLY SPECIFY)DISSOLUTION

ENHANCEMENT

ENHANCEMENT OF DISSOLUTION PROPERTIES OF

CANDESARTAN CILEXETIL USING LIQUISOLID TECHNIQUEDR. RAMESH D. PARMAR 212

312 25-Nov-19 182120820012 SAKRIYA EKTA BHOLABHAI MRW304P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

FORMULATION,OPTIMIZATION AND EVALUATION OF

AMORPHOUS SOLID DISPERSION OF CEFPODOXIME AXETILMR. DHAVAL D. MORI 212

313 25-Nov-19 182120820013 Thoriya jay chandreshkumar MRW304P 20 212 MP Pharmaceutics


FAST


FORMULATION AND EVALUATION OF BUCCAL FILM OF

REPAGLINIDEDR. JALPA S. PAUN 212

314 25-Nov-19 182120824005 PANDEY MEENAKSHI MANISHANKAR MRW304P 24 212 MPPharmaceutical

Quality

Assurance

STABILITY STUDIES


ESTIMATION OF ACOTIAMIDE HYDROCHLORIDE

TRIHYDRATE AND ITS RELATED SUBSTANCE

DR AMITKUMAR J. VYAS 212

315 25-Nov-19 182120824003 JADAV HINABEN MENANDBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING METHOD FOR SIMULTANEOUS ESTIMATION

OF ATORVASTATIN CALCIUM AND VITAMIN D3 BY RP-HPLC

DR. ASHOK B. PATEL 212

316 25-Nov-19 182120824007 PATEL DHRUTI MAHESHKUMAR MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

DEVELOPMENT AND VALIDATION OF STATBILITY

INDICATING ASSAY AND RELATED SUBSTANCE SUBSTANCE

OF CARIPRAZINE HYDROCHLORIDE BY HPLC

DR. NILESH K. PATEL 212

317 25-Nov-19 182120824014 VAGHASIYA EKTA HARSUKHBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

BIOANALYTICAL


VALIDATION FOR ESTIMATION OF NITROGLYCERIN AND ITS

METABOLITES IN K3EDTA HUMAN PLASMA BY USING LC-

ESI-MS/MS


318 25-Nov-19 182120824008 PATEL MAHINKUMAR PARESHBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


DEVELOPMENT AND VALIDATION FOR FIMASARTAN

POTASSIUM TRIHYDRATE AND ITS RELATED SUBSTANCES

BY HPLC


319 25-Nov-19 182120824011 RANA BHUMIKA HARISHBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES



RABEPRAZOLE SODIUM AND MOSAPRIDE CITRATE IN

TABLET DOSAGE FORM BY UPLC


320 25-Nov-19 182120824013 SHWETA GOSAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

SOLUBILITY STUDIES



ELTROMBOPAG OLAMINE AND ITS RELATED SUBSTANCE

BY HPLC

DR. AJAY I. PATEL 212

321 25-Nov-19 182120824006 PATEL ASTHA JAMANBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING



DEXTROMETHORPHAN HYDROBROMIDE AND

CHLORPHENIRAMINE MALEAT IN TABLET DOSAGE FORM

BY UPLC


322 25-Nov-19 182120824009 PRAJAPATI KRUPA BABUBHAI MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING


FOR ESTIMATION OF GENOTOXIC IMPURITIES IN HYDROXY

CHLOROQUINE SULFATE DRUG SUBSTANCE BY

CHROMATOGRAPHY


323 25-Nov-19 182120824004 KishnaRam MRW304P 24 212 MPPharmaceutical

Quality

Assurance

BABE


VALIDATION FOR ESTIMATION OF PHENYTOIN IN K3EDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS


324 25-Nov-19 182120824001 GOL DHRUVANSHIBEN ASHOKKUMAR MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF TADALAFIL AND

MACITENTAN IN SYNTHETIC MIXTURE USING RP-HPLC

DR. AMITKUMAR J. VYAS 212

325 25-Nov-19 182120824012 RAVAL DISHABEN HIMANSHUKUMAR MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

RP-HPLC METHOD DEVELOPMENT AND ITS VALIDATION

FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN

CALCIUM AND VITAMIN D3 IN TABLET DOSAGE FORM.

DR. AMITKUMAR J. VYAS 212

326 25-Nov-19 182120824010 RAHULKUMAR LAKHABHAI MAKWANA MRW304P 24 212 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


SIMULTANEOUS ESTIMATION OF RANOLAZINE AND

METFORMIN HYDROCHLORIDE IN SYNTHETIC MIXTURE


327 25-Nov-19 182150824003 THAKKAR HIREN GHANSHYAMBHAI MRW304P 24 215 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING HPTLC METHOD DEVELOPMENT

AND VALIDATION OF CLOMIPRAMINE HYDROCHLORIDE IN


DR. ZARNA DEDANIA 215

328 25-Nov-19 182150824004 THUTAN SHWETABEN KAVDUBHAI MRW304P 24 215 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES

STABILITY INDICATING HPLC METHOD DEVELOPMENT AND

VALIDATION FOR ITRACONAZOLE AND TERBINAFINE

HYDROCHLORIDE IN COMBINED PHARMACEUTICAL

DOSAGE FORM


329 25-Nov-19 182150824002 NISAD SAPNAKUMARI RAMRATAN MRW304P 24 215 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR

DETERMINATION OF ZONISAMIDE AND CILOSTAZOL IN

SYNTHETIC MIXTURE


330 25-Nov-19 182150824001 DIXIT ANMOL RAJENDRAPRASAD MRW304P 24 215 MPPharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION



FLUCONAZOLE AND ZINC PYRITHIONE IN LOTION

DR. GHANSHYAM

SHANGHANI215

331 25-Nov-19 182280822005 VAGHELA PUNIT VIJAYBHAI MRW304P 22 228 MPPharmaceutical


MEDICINAL

CHEMISTRY-ANTI-

TB AGENTS

DESIGN AND SYNTHESIS OF INDOLE-2-CARBOXAMIDES AS

POTENTIAL ANTI-TB AGENTSDR. TEJAS M. DHAMELIYA 228

332 25-Nov-19 182280822003 PATEL KISHAN RAMESHBHAI MRW304P 22 228 MPPharmaceutical


MEDICINAL

CHEMISTRY-

ANTIFUNGAL

AGENTS

DESIGN, SYNTHESIS AND EVALUATION OF SOME

THIAZOLOPYRIMIDINE DERIVATIVE AS ANTIFUNGAL

AGENTS

PROF. MAHESH T.

CHHABRIA228

333 25-Nov-19 182280822001 JADEJA SHWETABA BALBHADRASINH MRW304P 22 228 MPPharmaceutical

ChemistryOTHER (KINDLY SPECIFY) ANTI-TB AGENTS

DESIGN AND SYNTHESIS OF SOME NOVEL 1,3,4-

OXADIAZOLE ANALOGUES AS ANTI-TUBERCULAR AGENTSDR. DIPEN SUREJA 228

334 26-Nov-19 182280825006 PATEL VISHWABEN MUKESHBHAI MRW304P 25 228 MP Pharmacology

RESPIRATORY DISORDER (

PLEASE SPECIFY DISORDER

OR

EVALUTION OF ANTI FIBROTIC EFFECT OF OMEPRAZOLE

AND D- PENICILLAMINE IN BLEOMYCIN INDUCED LUNG

FIBROSIS IN MICE

DR. GAURANG B. SHAH 228

335 25-Nov-19 182280822004 Pradhan Sanmey vikasbhai MRW304P 22 228 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTIDIABETICS)

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF

DERIVATIVES OF 2-AMINO THIOPHENE AS ANTI-DIABETIC

AGENTS

PROF. ANURADHA K.

GAJJAR228

336 25-Nov-19 182310820002 MAKADIA RAVINABEN HAMIRBHAI MRW304P 20 231 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF BIFOCONAZOLE IN

SITU GEL FOR THRUSHDR. SANDIP PATEL 231

337 25-Nov-19 182310820003 MAKAVANA DHAVAL NARANBHAI MRW304P 20 231 MP Pharmaceutics OTHER (KINDLY SPECIFY)SOLUBILITY

ENHNCEMENT

SOLUBILITY ENHANCEMENT OF BCS CLASS II DRUG USING

SOLID DISPERSION TECHNIQUEMR. SUMIT CHAKRABORTY 231

338 25-Nov-19 182420824005 PATEL RUCHITA RAJUBHAI MRW304P 24 242 MPPharmaceutical

Quality

Assurance


DEVELOPMENT

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD

FOR ESTIMATION OF LURASIDONE AND ITS IMPURITIES

LURASIDONE 1 AND LURASIDONE 8

DR. ANKIT B. CHAUDHARY 242

339 25-Nov-19 182420824001 Bhayani Mital Arvindbhai MRW304P 24 242 MPPharmaceutical

Quality

Assurance

OTHER (KINDLY SPECIFY) QBD CONCEPTCOMPARATIVE STUDY OF QBD IMPLEMENTATION

PERSPECTIVE IN USA, EUROPE, JAPAN AND INDIADR. ANKIT B. CHAUDHARY 242

340 25-Nov-19 182420824002 DHARSANDIYA NIDHIBEN JENTILAL MRW304P 24 242 MPPharmaceutical

Quality

Assurance


DEVELOPMENT

DEVELOPMENT & VALIDATION OF RP-HPLC METHOD FOR

ESTIMATION OF TENELIGLIPTIN AND ITS IMPURITIES IN

TABLET

DR. ANKIT B. CHAUDHARY 242

341 25-Nov-19 182420824004 Patel Chiragkumar Kamleshkumar MRW304P 24 242 MP

Pharmaceutical

Quality

Assurance


DEVELOPMENT


FOR ESTIMATION OF DAPAGLIFLOZIN AND ITS IMPURITIES

DAPAGLIFLOZIN 3 AND DAPAGLIFLOZIN 37

DR. NAVNEET F. CHAUHAN 242

342 25-Nov-19 182420824003 MODI BIJAL JAYANTILAL MRW304P 24 242 MPPharmaceutical

Quality

Assurance

REGULATORY AFFAIRSCOMPARATIVE STUDY OF REGULATORY GUIDELINE OF

BIOWAIVERS IN DIFFERENT REGULATORY MARKETMS. JIGNA T. PATEL 242

343 25-Nov-19 182420824006 THAKAR RUCHIBEN ANILKUMAR MRW304P 24 242 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

DOLUTEGRAVIR AND LAMIVUDINE IN TABLET

MS. CHARMY D. PANDYA 242

344 25-Nov-19 182510820001 PATHAN SURAIYA ASHRAFKHAN MRW304P 20 251 MP Pharmaceutics

BUCO/MUCOADHESIVE,

TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF MEDICATED NAIL

LACQUER OF SERTACONAZOLE NITRATEDR. TUSHAR A. GOHIL 251

345 25-Nov-19 182510820002 SARVAIYA DIPASVIBEN DALPATBHAI MRW304P 20 251 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF COLON TARGETED

MINI TABLETS OF ORNIDAZOLEDR. TUSHAR A. GOHIL 251

346 25-Nov-19 182540822002 patel salman ismail MRW304P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW THIAZOLE DERIVATIVES AS

ANTICANCER AGENTSDR. M. N. NOOLVI 254

347 25-Nov-19 182540822001 MIRZA SOHANABIBI RAFIK MRW304P 22 254 MPPharmaceutical

Chemistry

MEDICINAL CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW DIAMINO PYRIMIDINE DERIVATIVES AS

ANTICANCER AGENTSDR. M. N. NOOLVI 254

348 25-Nov-19 182540822003 RANA MAHIRAKHATUN RANJITSINH MRW304P 22 254 MPPharmaceutical


ANTI-ALZHEIMER

AGENTS

SYNTHESIS OF NEW FLAVONOL DERIVATIVES AS ANTI-

ALZHEIMER AGENTSDR. MORE UTTAM 254

349 25-Nov-19 182540822004 Vaja Mukesh MRW304P 22 254 MPPharmaceutical


ANTI-TUBERCULAR

AGENTS

SYNTHESIS OF NEW DIPHENYL ETHER DERIVATIVES AS

ANTI-TUBERCULAR AGENTSDR. MORE UTTAM 254

350 25-Nov-19 182610820001 DAXINI KAPILKUMAR VINODBHAI MRW304P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY)BIOAVAILABILITY

ENHANCEMENT

FORMULATION DEVELOPMENT FOR OPTIMIZING DELIVERY

OF POORLY BIOAVAILABLE DRUG BASED ON MODULATION

OF THE ROLE OF PGP EFFLUX PUMP

DR.JIGAR VYAS 261

351 25-Nov-19 182610820002 PATEL JUHIBEN HARIKRUSHNABHAI MRW304P 20 261 MP Pharmaceutics OTHER (KINDLY SPECIFY)SOLUBILITY

ENHANCEMENT

FORMULATION AND DEVELOPMENT OF LIQUISOLID

TABLET OF POORLY SOLUBLE DRUGDR.JITENDRA PATEL 261

352 25-Nov-19 182610820003 PATEL RIA NITINBHAI MRW304P 20 261 MP Pharmaceutics MULTIPARTICULATE

FORMULATION AND DEVELOPMENT OF LULICONAZOLE

MICROSPONGES FOR TOPICAL DELIVERY SYSTEM USING

QBD APPROACH

DR.CHAINESH SHAH 261

353 25-Nov-19 182610824002 Solanki Jaydipsinh Manharsinh MRW304P 24 261 MP

Pharmaceutical

Quality

Assurance

DISSOLUTION STUDIES

DISSOLUTION METHOD DEVELOPMENT AND VALIDATION

OF THE METFORMIN HYDROCHLORIDE(SR) AND

TENELIGLIPTIN IN COMBINED DOSAGE FORM BY RP-HPLC

MRS.PUJA VYAS 261

354 25-Nov-19 182690824005 MINIYA PRIYANKABEN PARESHBHAI MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

STABILITY STUDIES


INDICATING RP-HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF MIFEPRISTONE AND MISOPROSTOL IN ITS

ORAL SOLID DOSAGE FORM

DR SIBAJI SARKAR 269

355 25-Nov-19 182690824009 VADGAMA TEJAS RAMNIKLAL MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING

DEVELOPMENT AND VALIDATION OF STABILITY-


BEXAROTENE AND ITS IMPURITIES IN ORAL SOLID DOSAGE

FORM


356 25-Nov-19 182690824002 GAJERA BINAL ASHOKBHAI MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING

DEVELOPMENT AND VALIDATION OF A STABILITY-

INDICATING RP-HPLC METHOD FOR ESTIMATION OF

SODIUM VALPROATE AND VALPROIC ACID ALONG WITH

IMPURITIES FROM A COMBINED ORAL SOLID DOSAGE

FORM


357 25-Nov-19 182690824008 THESIYA SWATIBEN DHEERUBHAI MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF A STABILITY-

INDICATING METHOD FOR THE SIMULTANEOUS

ESTIMATION OF AMBROXOL AND DOXYCYCLINE USING

THE RP-HPLC METHOD

D.K TARAI 269

358 25-Nov-19 182690824006 PAL ARCHANA HARIRAM MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF MIFEPRISTONE AND

MISOPROSTOL IN IT’S COMBINED PHARMACEUTICAL

DOSAGE FORM.

KOMAL R. DHUDASHIA 269

359 25-Nov-19 182690824003 KALOLA NENSI AMRUTLAL MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

SIMULTENEOUS

ESTIMATION


FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE AND

PROPRANOLOL IN COMBINED DOSAGE FORM BY USING RP-

HPLC METHOD.


360 25-Nov-19 182690824001 Faldu Jay Maganlal MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING


INDICATING RP-HPLC METHOD FOR LURASIDONE AND ITS

IMPURITIES IN PHARMACEUTICAL DOSAGE FORM

D.K TARAI 269

361 25-Nov-19 182690824007 SOLANKI HINALBEN KISHORBHAI MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance

IMPURITY PROFILING


INDICATING RP-HPLC METHOD FOR VORTIOXETINE AND

ITS IMPURITIES IN PHARMACEUTICAL DOSAGE FORM

D.K TARAI 269

362 25-Nov-19 182690824004 Kanetiya Mansiben Mukeshbhai MRW304P 24 269 MP

Pharmaceutical

Quality

Assurance


RELATED

IMPURITIES (IN-

PROCESS

IMPURITIES)


FOR THE ESTIMATION OF TERIFLUNOMIDE AND ITS

RELATED IMPURITIES IN IT’S ORAL SOLID DOSAGE FORM.


363 25-Nov-19 182820824002 BANGIYA MINHAJ IKBAL MRW304P 24 282 MPPharmaceutical

Quality

Assurance

PROCESS VALIDATION


AND VALIDATION FOR ESTIMATION OF BEPOTASTINE

HYDROCHLORIDE IN ITS BULK

DR. M.B.SHANKAR 282

364 25-Nov-19 182820824003 Thavrani Kajal Paresh MRW304P 24 282 MP

Pharmaceutical

Quality

Assurance

PROCESS VALIDATION


INDICATING ASSAY METHOD FOR ATAZANUVIR SULPHATE

IN BULK DRUG AND CAPSULE DOSAGE FORM AND ITS

APPLICATION IN DISSOLUTION BY RP-HPLC.

DR. M.B.SHANKAR 282

365 26-Nov-19 182050825003 CHANDEL ATULSINGH JAYNARAYANSINGH MRW304P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF NLRP3 INFLAMMASOME INHIBITOR IN

EXPERIMENTALLY INDUCED CARDIAC FIBROSIS IN

UNINEPHRECTOMIZED RATS

DR. TEJAL GANDHI 205

366 26-Nov-19 182050825004 GAJERA HARSHKUMAR BHARATBHAI MRW304P 25 205 MP Pharmacology CVS DISORDEREVALUATION OF PROTECTIVE EFFECT OF SNAIL-1

INHIBITOR IN CARDIAC FIBROSIS IN EXPERIMENTAL RATS DR. TEJAL GANDHI 205

367 26-Nov-19 182050825005 KAZI ASFIYA JAVIDALI MRW304P 25 205 MP Pharmacology CVS DISORDEREVALUATION OF ANTHRAQUINONE RICH FRACTION OF

RHUBARB IN CARDIAC FIBROSIS IN EXPERIMENTAL RATSDR. SARIKA JOHARI 205

368 26-Nov-19 182050825007 RANA KHYATI MUKESHBHAI MRW304P 25 205 MP Pharmacology CVS DISORDER

EVALUATION OF CARDIOPROTECTIVE EFFECT OF

RANOLAZINE IN HIGH FAT DIET AND STREPTOZOTOCIN

INDUCED DIABETIC CARDIOMYOPATHY


369 26-Nov-19 182050825008 SAIYED FALAKAARA HASHMATALI MRW304P 25 205 MP Pharmacology CVS DISORDERSTUDY OF CARDIOPROTECTIVE EFFECT OF PRASUGREL IN

MYOCARDIAL ISCHEMIA/REPERFUSION INJURY DR. TEJAL GANDHI 205

370 26-Nov-19 182050825010 Thakkar Brijesh Jayendra MRW304P 25 205 MP Pharmacology CVS DISORDEREFFECT OF PPAR ?/G DUAL AGONIST IN STREPTOZOTOCIN

INDUCED DIABETIC CARDIOMYOPATHY IN RATSDR. TEJAL GANDHI 205

371 26-Nov-19 182050825002 Chanchal Yadav MRW304P 25 205 MP Pharmacology RENAL DISORDERSEVALUATION OF ANTI-UROLITHIATIC EFFECT OF HERBAL

FORMULATIONS IN EXPERIMENTAL RATSDR. TEJAL GANDHI 205

372 26-Nov-19 182050825009 SANCHANIYA DIVYA ARVINDBHAI MRW304P 25 205 MP Pharmacology RENAL DISORDERS

EFFECT OF SAPONIN AND FLAVONOID RICH EXTRACTS OF

BRYOPHYLLUM PINNATUM ON CRYSTAL DEPOSITION IN

EXPERIMENTAL UROLITHIASIS


373 26-Nov-19 182050825001 AGHERA CHIRAGKUMAR RASIKLAL MRW304P 25 205 MP Pharmacology TOXICITY STUDYSYSTEMATIC TOXICOLOGICAL EVALUATION OF NATURAL

FLAVONOID QUERCETIN IN RODENTSDR. SARIKA JOHARI 205

374 26-Nov-19 182120825003 KRITIKA RAINA MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF

PETROSELINUM CRISPUM LEAVES EXTRACT BY FREUNDS

ADJUVANT INDUCED ARTHRITIS IN RATS

DR. RAVI A. MANEK 212

375 26-Nov-19 182120825004 MAJITHIA BRINDA RAJESHBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO

MODULATORY`

EVALUATION OF IMMUNOMODULATORY AND ANTI-

INFLAMMATORY ACTIVITY OF POLYHERBAL FORMULATION

BY EXPERIMENTAL ANIMAL MODELS IN RATS


376 26-Nov-19 182120825007 PATEL VRUTTI THAKORBHAI MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF EFFECT OF ETHANOLIC EXTRACT OF

FAGONIA CRETICA L. PLANT AGAINST EXPERIMENTALLY

INDUCED ULCERATIVE COLITIS IN RATS

DR. DEVANG B. SHETH 212

377 26-Nov-19 182120825008 sorathiya kirti dineshbhai MRW304P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)IMMUNO-

INFLAMMATORY

EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF

MEDICAGO SATIVA L. SPROUTS ON CHEMICAL INDUCED

ULCERATIVE COLITIS IN RATS

DR. JIGNESH I. PATEL 212

378 26-Nov-19 182120825001 KANABAR KRINA BHUPATBHAI MRW304P 25 212 MP Pharmacology

METABOLIC DISORDER (

PLEASE SPECIFY

DISORDER)

ASSESSMENT OF DIABETIC WOUND HEALING POTENTIAL

OF AZADIRACHTA INDICA LEAVES EXTRACT USING IN-

VITRO AND IN-VIVO ASSAYS

DR. DEVANG B. SHETH 212

379 26-Nov-19 182120825002 KHILJI RUKHSHAR BANU MRW304P 25 212 MP Pharmacology


PLEASE SPECIFY

DISORDER)

EVALUATION OF ANTI-DIABETIC ACTIVITY OF POLYHERBAL

FORMULATION IN EXPERIMENTALLY INDUCED DIABETES IN

RATS


380 26-Nov-19 182130825001 DHAMANE DIVYANSHI AVINASH MRW304P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF SAXAGLIPTIN 2.5 MG AND

METFORMIN 1000 MG FILM COATED TABLETS IN FED

CONDITIONS

DR. DIGVIJAYSINH G. RANA 213

381 26-Nov-19 182130825002GHODASARA DENISHKUMAR

DINESHKUMARMRW304P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF FEBUXOSTAT FILM COATED

TABLETS 80 MG IN FASTING CONDITIONSDR. DIGVIJAYSINH G. RANA 213

382 26-Nov-19 182130825003 sardhara shivani rajendrakumar MRW304P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)REPRODUCTIVE

DISEASES

A RETROSPECTIVE STUDY OF DRUG UTILIZATION IN

GYNAECOLOGICAL INFECTIONS DR. DEEPTI K. JANI 213

383 26-Nov-19 182150827001 DESAI GRISHMABEN KETANBHAI MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A STUDY ON REGULATORY REQUIREMENT FOR

REGISTRATION OF SIROLIMUS ELUTING CORONARY STENT

IN INDIA, EU AND TAIWAN

DR. RONAK DEDANIA 215

384 26-Nov-19 182150827002 PANDEY JYOTI GORAKHNATH MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRSCURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS

IN INDIA AND CANADADR. RONAK DEDANIA 215

385 26-Nov-19 182150827008 SINGH SHOBHA SATENDRA MRW304P 27 215 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

DOSSIER SUBMISSION OF DRUG CONTAINING

ROSUVASTATIN TABLET AS PER REGISTRATION GUIDELINES

OF RUSSIA AND COMPARE RUSSIAN GUIDELINES WITH

EUROPEAN GUIDELINES

DR. VINEET JAIN 215

386 26-Nov-19 182150827009 VANI NAMRATA SURESHCHANDRA MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

DOSSIER PREPARATION OF DRUG CONTAINING

CLARITHROMYCIN TABLET AS PER GUIDELINE IN UGANDA

AND IT’S COMPARISON WITH INDIA


387 26-Nov-19 182150827004 PATEL NILIMA DHIRUBHAI MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

TO PREPARE A DOSSIER CONTAINING LEVOFLOXACIN

TABLET FOR REGISTRATION IN MYANMAR AND IT’S

COMPARISON WITH USA

DR. VINEET JAIN 215

388 26-Nov-19 182150827006 SHAH KINJAL VINAY MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

REGULATORY REQUIREMENT FOR DOSSIER SUBMISSION

FOR DICLOFENAC POTASSIUM AND LOPERAMIDE IN

NIGERIA


389 26-Nov-19 182150827007 SHIRSATH ARCHANA SATISH MRW304P 27 215 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

CURRENT REGULATORY REQUIREMENT FOR

REGISTRATION OF ONCOLOGICAL PRODUCT IN MYANMAR,

INDIA AND NEPAL

DR. VINEET JAIN 215

390 26-Nov-19 182280825002 HIMIKA HASMUKHBHAI RATHI MRW304P 25 228 MP Pharmacology CNS DISORDEREVALUATION OF DOPAMINE RECEPTOR MODULATORS ON

MORPHINE TOLERANCE AND ADDICTION IN MICE

DR. MEHUL R.

CHORAWALA228

391 26-Nov-19 182280825003 PANCHAL VIDHI NATVARLAL MRW304P 25 228 MP Pharmacology CVS DISORDEREVALUATION OF PROTECTIVE EFFECTS OF PHLORIZIN IN

EXPERIMENTALLY INDUCED MYOCARDIAL I/R INJURY.DR. ANITA A. MEHTA 228

392 26-Nov-19 182280825007 PUROHIT SWETA HAREH MRW304P 25 228 MP Pharmacology CVS DISORDEREVALUATION OF CARDIOPROTECTIVE EFFECTS OF

CILOSTAZOL IN I/R INJURY IN ISOLATED RAT HEART DR. ANITA A. MEHTA 228

393 26-Nov-19 182280825009 Trivedi Mansi Vinod kumar MRW304P 25 228 MP Pharmacology CVS DISORDER

EVALUATION OF CARDIOPROTECTIVE ACTIVITY OF

METFORMIN, RESVERATROL AND BERBERINE ALONE AND

IN COMBINATION IN ISOPROTERENOL INDUCED HEART

FAILURE IN RATS


394 26-Nov-19 182280825005 Patel Krupa Dineshkumar MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASEEFFICACY STUDY OF CAMEL MILK AND EPALRESTAT

AGAINST HEPATOTOXICITY IN RATS

DR. MUSTAKIM M.

MANSURI228

395 26-Nov-19 182280825008 TRIPATHI ASHUTOSH RAMASHANKER MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY)AUTO IMMUNE

DISORDER

STUDY OF SEROTONINS ROLE IN CFA INDUCED ARTHRITIS

IN RATS

DR. MUSTAKIM M.

MANSURI228

396 26-Nov-19 182280825010 VAGHELA KIRAN BHARATKUMAR MRW304P 25 228 MP Pharmacology OTHER (KINDLY SPECIFY) LIVER DISEASE

COMPARATIVE EFFICACY STUDY OF LIVE AND HEAT KILLED

SACCHAROMYCES CEREVISIAE IN COMBINATION WITH

SODIUM SELENATE IN CCL4 INDUCED LIVER FIBROSIS IN

RAT


397 26-Nov-19 182280825001 Chettiar Poojashree Boopathyraj MRW304P 25 228 MP Pharmacology CANCER

EVALUATION OF ANTICANCER MODULATING EFFICAY OF

ACANTHUS ILLICIFOLIUS AND MUSA PARADISIACA ALONG

WITH DOCETAXEL ON PROSTATE CANCER CELLS

DR. SUNITA GOSWAMI 228

398 25-Nov-19 182280822002 PATEL APEXA NAVNEETBHAI MRW304P 22 228 MPPharmaceutical


INFECTIOUS

DISEASE

LEAD MODIFICATION STUDIES OF A SERIES OF

PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS POTENTIAL

ANTI-MYCOBACTERIAL AGENTS

DR. MAHESH T. CHHABRIA 228

399 26-Nov-19 182390825001 DAVDA BHAKTI KAILESH MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) PCOS

EFFECT OF BAUHINIA PURPUREA BARK EXTRACT AND

ANETHUM GRAVEOLENS FRUIT EXTRACT ON

EXPERIMENTALLY INDUCED POLYCYSTIC OVARY

SYNDROME IN RATS

DR. ARINDAM PAUL 239

400 26-Nov-19 182390825002 JAINEE DAXESH VASHI MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) BPH

EFFECT OF POLYHERBAL FORMULATION AGAINST

EXPERIMENTALLY INDUCED MODELS OF BENIGN

PROSTATIC HYPERPLASIA IN RATS

MR. MITTAL DALAL 239

401 26-Nov-19 182390825007 SALUNKE SNEHAL SHRIKANT MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY)ANTI-

HEMORRHOID

PHARMACOLOGICAL EVALUATION OF ANTI-

HEMORRHOIDAL POTENTIAL OF POLYHERBAL

FORMULATIONS AGAINST CROTON OIL INDUCED MODEL

IN RATS


402 26-Nov-19 182390825009 TANDEL DIVYA JITENDRA MRW304P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY) ARTHRITIS

EFFECT OF DIOSCOREA HISPIDA DENNST. TUBER ON

EXPERIMENTALLY INDUCED RHEUMATOID ARTHRITIS AND

GOUT IN RATS


403 26-Nov-19 182390825004 MAITRI RAJESH KALAN MRW304P 25 239 MP Pharmacology TOXICITY STUDYSUBCHRONIC TOXICITY STUDY OF T-AYU-HM™ PREMIUM :

A HERBOMINERAL FORMULATIONDR. ANKIT MERAI 239

404 26-Nov-19 182390825003 Lakhani Ruchita Sahbudin MRW304P 25 239 MP Pharmacology

G.I. TRACT ( PLEASE

SPECIFY DISORDER OR

DISEASE)

EVALUATION OF LAXATIVE EFFECT OF VASULAX - A

POLYHERBAL FORMULATION.DR. ARINDAM PAUL 239

405 26-Nov-19 182390825005 Megha Menon MRW304P 25 239 MP Pharmacology

G.I. TRACT ( PLEASE

SPECIFY DISORDER OR

DISEASE)

CYTOPROTECTIVE EFFECT OF IN-SITU GEL CONTAINING

TANNINS AGAINST EXPERIMENTALLY INDUCED PEPTIC

ULCER IN RATS


406 26-Nov-19 182390825006 MULLA KAYNAT MUSTAQ MRW304P 25 239 MP Pharmacology

G.I. TRACT ( PLEASE

SPECIFY DISORDER OR

DISEASE)

EFFECT OF POLYHERBAL FORMULATION, ACIDEZ, AGAINST

EXPERIMENTALLY INDUCED GASTRIC ULCER IN RATSDR. ANKIT MERAI 239

407 26-Nov-19 182390825008 TAILOR SHIVANGI ISHWARBHAI MRW304P 25 239 MP Pharmacology


PLEASE SPECIFY

DISORDER)

EFFECT OF SOYBEAN EXTRACT AND CISSUS

QUADRANGULARIS AQUEOUS EXTRACT IN

OVARIECTOMIZED RAT MODEL


408 26-Nov-19 182440825001 Makwana Payalben Dhirubhai MRW304P 25 244 MP Pharmacology CLINICAL STUDYASSESSMENT OF QUALITY OF PRESCRIPTION AT ICUS IN A

TERTIARY CARE TEACHING HOSPITALDR. SAMIR K. SHAH 244

409 26-Nov-19 182680825001 CHAUDHARI FALGUNIKUMARI SATISHBHAI MRW304P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)

ANALGESIC AND

ANTI-

INFLAMMATORY

EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY

ACTIVITIES OF MANILKARA HEXANDRA (ROXB.) IN WISTAR

RATS

DR. VIJAY B. LAMBOLE 268

410 26-Nov-19 182680825002 PATEL CHARMIBEN JAYANTIBHAI MRW304P 25 268 MP Pharmacology RENAL DISORDERSEVALUATION OF ANTIUROLITHIATIC POTENTIAL OF

MANILKARA HEXANDRA (ROXB.) IN WISTAR RATSDR. VIJAY B. LAMBOLE 268

411 26-Nov-19 182680825003 PRAJAPATI ANKITKUMAR BHARATBHAI MRW304P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY) JOINTS

EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF ABIES

WEBBIANA LINDI. ON EXPERIMENTALLY INDUCED

ARTHRITIS MODEL IN RATS

MR. VIPULKUMAR GAJERA 268

412 26-Nov-19 182820829004 CHAUDHARI LOKITABEN ANILKUMAR MRW304P 29 282 MPClinical

Pharmacy

PHARMACY PRACTICE &

CLINICAL STUDY

(DIABETES)

TO STUDY THE BENEFICIARY EFFECT OF METFORMIN +

SITAGLIPTIN COMBINATION VS METFORMIN ALONE IN

TYPE 2 DIABETIC PATIENTS.

DR. HETAL D. SOLANKI 282

413 26-Nov-19 182820829006 RATHOD TARUN JETHABHAI MRW304P 29 282 MPClinical

PharmacyBABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF URSODEOXYCHOLIC

ACID CAPSULE IN HEALTHY, ADULT, MALE HUMAN

SUBJECTS UNDER FASTING CONDITION

DR. JIGNESH SHAH 282

414 26-Nov-19 182820829007 SHUKLA BHARGAV DINESHCHANDRA MRW304P 29 282 MPClinical

PharmacyBABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF GLIPIZIDE EXTENDED

RELEASE TABLET IN HEALTHY, ADULT, MALE HUMAN

SUBJECTS UNDER FED CONDITION

DR. JIGNESH SHAH 282

415 26-Nov-19 182820829005 KARAN KALPESH BAJANIYA MRW304P 29 282 MPClinical

PharmacyBABE STUDY

TO ESTABLISH BIOEQUIVALENCE OF SODIUM VALPROATE

ORAL SOLUTION IN HEALTHY, ADULT, MALE HUMAN

SUBJECTS UNDER FASTING CONDITION


416 26-Nov-19 182820829008 VANDANA AMIT SHARMA MRW304P 29 282 MPClinical

PharmacyOTHER (KINDLY SPECIFY)

PHARMACOVIGILA

NCE

A STUDY ON CLINICAL PATTERN OF ADVERSE DRUG

REACTIONS TO THE DRUGS USED FOR HYPERTENSION AND

ASSESMENT OF MEDICATION KNOWLEDGE IN SUCH

PATIENTS.

DR. JIGNESH G. SHAH 282

417 26-Nov-19 182820829001 KAZI ANJUMARA ZAKIRMIYA MRW304P 29 282 MPClinical

PharmacyCLINICAL STUDY (CVS)

TO COMPARE THE PRESCRIBED ANTIHYPERTENSIVE

MEDICATION USE AND BLOOD PRESSURE CONTROL IN

TERTIARY AND PRIMARY HEALTH CARE CENTRE, ANAND.


418 26-Nov-19 182820829002 PANDYA SHIVANGI BIPINCHANDRA MRW304P 29 282 MPClinical

PharmacyCLINICAL STUDY (CVS)

A COMPARATIVE STUDY OF NIFEDIPINE AND LABETALOL IN

PREGNANCY INDUCED HYPERTENSIONDR. HETAL D. SOLANKI 282

419 26-Nov-19 182820829003 PATEL PRACHI SHAILESHKUMAR MRW304P 29 282 MPClinical

PharmacyOTHER (KINDLY SPECIFY) SKIN INFECTIONS

TO STUDY THE AWARENESS OF SKIN INFECTION AMONG

ADULTS AT TERTIARY CARE CENTRE, ANAND.DR. HETAL D. SOLANKI 282

420 26-Nov-19 182880827002 BARAIYA KOMALBEN BHASKARRAY MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & HEALTH CANADA FOR EYE DROPS AND

PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR LIFITEGRAST EYE DROPS AS PER

USFDA

DR. KASHYAP THUMMAR 288

421 26-Nov-19 182880827005 KU SADHVI DHARAMNARAYAN TIWARI MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRSTO PROCESS COMPILE & VALIDATE CMC PART OF ANDA

SUBMISSION IN e-CTD FORMATMR. PRAVEEN JAIN 288

422 26-Nov-19 182880827006 MAURYA PRITIKUMARI RADHESHYAM MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

RIVASTIGMINE EXTENDED RELEASE FILM 4.6MG/24

HOURS - A GENERIC PRODUCT TO EXELON: PREPARATION

OF DRAFT ABBREVIATED NEW DRUG APPLICATION (ANDA)

FOR REGISTRATION IN USA

DR. R.H.PARIKH 288

423 26-Nov-19 182880827007 MEHTA HETAL MANISHKUMAR MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A STUDY ON REGISTRATION PROCESS OF FEBUXOSTAT

FILM COATED TABLET AS PER CENTRALISED PROCEDURE

OF EUROPEAN MEDICINE AGENCY (EMA)

DR. R.H.PARIKH 288

424 26-Nov-19 182880827014 ZALA TWINKLE DHANJIBHAI MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

COMPARATIVE GLOBAL REGULATORY APPROACH

TOWARDS NITROSAMINE IMPURITIES AND TO PREPARE

GUIDANCE DOCUMENT FOR INDIAN REGULATION

MR.NIRAV CHOKSHI 288

425 26-Nov-19 182880827009 Panchal kinjal pankajbhai MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

PREPARATION OF DRAFT ACTD DOSSIER FOR

COMBINATION OF ARTEMETHER AND LUMEFANTRINE AS

A POWDER FOR ORAL SUSPENSION AND A STUDY ON

IMPLEMENTATION OF VARIATION AS PER ASEAN

GUIDELINE


426 26-Nov-19 182880827001 ACHARYA SHARAD HARILAL MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRSTO PROCESS, COMPILE, FILE TAGGING & VALIDATE

CLINICAL PART OF ANDA SUBMISSION IN e-CTD FORMATMR. PRAVEEN JAIN 288

427 26-Nov-19 182880827003 DAVE KEYUR PIYUSHKUMAR MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A STUDY ON REGISTRATION PROCESS AS PER USFDA FOR

INTRAVENOUS COMBINATION OF CEFTOLOZANE SULFATE

& TAZOBACTAM SODIUM - A GENERIC PRODUCT TO

ZERBAXA

DR. R.H.PARIKH 288

428 26-Nov-19 182880827004 KHAMAR VIDHI VINAYBHAI MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

ARFORMOTEROL TARTRATE INHALATION SOLUTION :

PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) AS PER USFDA

DR. VISHWAS RANPARIYA 288

429 26-Nov-19 182880827010 PAREKH ISHANI HITESHKUMAR MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A STUDY ON ABBREVIATED NEW DRUG APPLICATION

(ANDA) REGISTRATION PROCESS FOR CANAGLIFLOZIN

TABLET AS PER USFDA.

MS. DIPA MEHTA 288

430 26-Nov-19 182880827011 PATEL NIDHI HASMUKHBHAI MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS

IN INDIA & USA FOR MEDICAL DEVICES AND A STUDY OF

PRODUCT APPROVAL PROCESS FOR IN-VITRO DIAGNOSTICS

(IVDS) AS PER INDIAN REGULATORY SYSTEM


431 26-Nov-19 182880827012 revati kabariya MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A STUDY ON BIOSIMILAR PRODUCT REGISTRATION

PROCESS FOR PERTUZUMAB INJECTION THROUGH

CENTRALISED PROCEDURE AS PER EMA

MS. DIPA MEHTA 288

432 26-Nov-19 182880827008 MOURYA MAMTASHANTI SHAMBHUNATH MRW304P 27 288 MP

Pharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRS

A COMPARISON OF REGULATORY REQUIREMENTS AS PER

USFDA & SOUTH AFRICA FOR POWDER FOR INJECTION

AND PREPARATION OF DRAFT ABBREVIATED NEW DRUG

APPLICATION (ANDA) FOR ENFUVIRTIDE POWDER FOR

INJECTION AS PER USFDA

DR.KASHYAP THUMMAR 288

433 26-Nov-19 182880827013 ROHIT KUMAR MRW304P 27 288 MPPharmaceutical

Regulatory

Affairs

REGULATORY AFFAIRSMODEL DOSSIER FOR WHO PREQUALIFICATION AND

IMPLEMENTATION OF VARIATION AS PER WHO GUIDELINEMR.NIRAV CHOKSHI 288

S/d

I/C Contoller of Examination

gujarat technological university student list for m.pharm ...... · hydrochloride in fixed dose...

Documents